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ABSTRACT 
The carcinogenic nephrotoxin Ochratoxin A (OTA) is a 
widespread natural contaminant of a variety of food and 
feedstuffs. The effect of OTA on renal lipid peroxidation and 
on renal cortical endoplasmic reticular ATP-dependent calcium 
uptake were investigated. 
OTA did not stimulate NADPH-dependent lipid peroxidation 
(malondialdehyde formation) in the kidney, either in vivo or 
in vitro. It also did not induce any of several antioxidative 
enzymes in vivo under our experimental conditions. 
Administration of a single high dose or multiple lower doses 
of OTA to rats did result in an increase of the renal cortical 
endoplasmic reticular ATP-dependent calcium pump activity. 
This increase was very rapid, being evident within 10 minutes 
of OTA administration, and remained elevated for at least 6 
hours thereafter. This change in calcium uptake is the 
earliest enzymatic change reported in the kidney after OTA 
administration. 
In vitro preincubation of microsomes with NADPH had a 
profound inhibitory effect on calcium uptake. Inclusion of 
OTA was able to reverse the inhibition. Addition of OTA alone 
to cortical microsomes during calcium uptake inhibited the 
uptake procE::ss, although the effect was reversible. However, 
it does not appear that in vivo OTA exerts a significant 
ii 
·-: (, 
direct inhibitory effect on renal cortical calcium uptake 
activity since an increase in this activity was observed after 
OTA administration. 
Changes in the rates of microsomal calcium uptake were 
correlated with changes in the steady-state levels of the 
phosphorylated Mg2•;ca2•-ATPase intermediate suggesting that in 
vivo/in vitro conditions were affecting the rate of enzyme 
phosphorylation. 
Study of OTA analogues indicated that the presence of a 
free carboxyl group and chlorine atom on OTA contributed 
significantly to the effect on calcium uptake. 
These results suggest that lipid peroxidation may not be 
responsible for the initiating OTA nephrotoxicity. However, 
alterations in calcium homeostasis as evidenced by an increase 
in microsomal calcium pump activity could play a significant 
role in OTA nephrotoxicity. 
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1.1 Ochratoxin A 
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CHAPTER 1 
1. INTRODUCTION 
1.1.1 sources, occurrence and properties 
The ochratoxins encompass a group of closely-related 
secondary metabolites of the fungi Penicillium and 
Aspergillus. These fungi are ubiquitous and the potential for 
contamination of foodstuffs and anim::.l feed is widespread. 
Ochratoxin A (OTA), the major metabolite and the most toxic of 
the ochratoxins, has been found in a number of countries 
worldwide, mainly in Europe. Ochratoxins formation by 
Aspergillus species appears to be limited to conditions of 
high humidity and temperature, whereas at least some 
Penicillium species may produce ochratoxin at temperatures as 
low as 5°C [WHO, 1990]. 
Following the discovery of ochratoxins by De Scott in 
1965, OTA, the 7-carboxy-5-chloro-8-hydroxy-1,4-dihydro-3-R-
methylisocoumarin amide of L-/3-phenylalanine, was isolated 
together with its less toxic analogue, ochratoxin B (OTB) 
(dechloro-ochratoxin A) from a culture of Aspergillus 
ochraceus (Merwe et al, 1965a&b]. The ochratoxin group (Fig. 
1) consists of OTA; OTB; methyl ester of OTA, 
Fig. l. 
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The chemical structure of ochratoxins 
0 OH 
II 
HO-C 
Cl 
H 
Ochratoxin a ( OTa ) 
Ochra to:cin - . •!.• •r ... = cl; 
Ochratoxin B; X H; 
Ochratoxin C: X = Cl; 
Rl 
-
H 
Rl 
-
H 
nl 
-
CH3 
3 
ochrato>~:in C (OTC); 4-hydroxyochratoxin A~ hydrolysed OTT\ 
(isocoumarin part), ochratoxin a; methyl ester of OTB; methyl 
and ethyl esters of OTT\. OTA and, very rarely, OTB are the 
only compounds found as natural contaminants in plant 
material, and most information available concerns OTA [Who, 
1990]. OTT\ is very stable in ethanol at 0-4°C; however, sach 
solutions are light sensitive, since decomposition occurs on 
exposure to fluorescent 1 ight for several days. OTA is a 
colourless, crystalline compound, obtained by crystallization 
from benzene, with a melting point of about 90°C. It is 
soluble in polar organic solvents, slightly soluble in water, 
and soluble in dilute aqueous bicarbonate. OTA is also 
optically active. 
Both OTA and OTB have been found as natural contan~nants 
of food, feed and their products, though OTB occurs extremely 
rarely. Agricultural commodities in which OTA has been 
detected include corn, wheat, rye, hay, barley, oats, sorghum, 
groundnuts, coffee beans, etc. at levels ranging from 5 -
27,500~g/Kg (WHO, 1979]. The levels vary significantly from 
country to country. In Canada, Scott et al (1972] detected 
OTA in concentrations of up to 27 ppm in 18 out of 29 samples 
of heated grain from Saskatchewan farms. Abrahamson et al 
( 1983] also showed 7. 8% of mixed animal feed from western 
canada was contaminated with OTA at levels ranging from 48 -
5900 p.g/Kg. 
4 
Residues of OTA are not generally found in ruminants, 
because OTA is cleaved in the forestomach by protozoan and 
bacterial enzymes [Gal tier & Alvinerie, 1976; Hult et al., 
1976; Patterson et al., 1981). The non-toxic acid hydrolysate 
of OTA, OTa, is a cleavage product found in the intestine, 
feces, urine, kidneys, and liver of rodents experimentally fed 
an OTA-containing diet {Galtier & Alvinerie, 1976]. Residues 
of OTA have been detected in a number of tissues in single-
stomach animals, such as the pig. Data on levels of OTA 
[ Roschenthaler et al, 1984] indicate that when contamination 
of feed by OTA is significant, the mycotoxin can occur 
commonly in swine kidney and liver, in smoked meat products, 
and in the blood of slaughtered swines. These data indicated 
that 83% of the samples contained <200JLg/Kg OTA, but a few 
contained the level of OTA as high as 920J.Lg/Kg. The highest 
levels of OTA residues were normally found in kidneys with 
lower levels in the liver, muscle, and adipose tissue (Krogh 
et al, 1974). OTA is present in the blood bound to serum-
albumin [ Chu, 1971; Gal tier, 1974a &b) and as free OTA; 
saturation (in the rat) occurs at 70 mg OTA/L plasma. In 
Western Canada, it was reported that 3. 6 - 4. 2% of 1200 pig 
blood samples, collected from slaughterhouses during 1986, 
contained OTA at concentrations higher than 20 ng/mL 
[Marquardt et al, 1988]. The binding of OTA to serum albumin 
is particularly strong in cattle, pigs, and man, based on in 
5 
vitro studies [Galtier, 1979]. Chu showed that serum albumin 
bound two equivalents of OTA tightly ( 1971 J • 
The potential for human exposure to OTA is very high 
because of the consumption of contaminated food. Recently, 
OTA has been detected in the blood of 6-18% of the human 
population -tn some areas where Balkan endemic nephropathy is 
prevalent [WHO, 1990]. OTA has also been found in human blood 
samples outside the Balkan peninsula. In some studies, more 
than 50% of the samples analyzed were contaminated (WHO, 
1990). A high incidence of tumours of the urinary system is 
strongly correlated with the prevalence of Balkan endemic 
nephropathy [Krogh, 1977, Krogh et al 1977 J. The froquoncy of 
occurrence of this disease is correlated with relatively high 
concentrations of OTA in the food from endemic reg ions (Krogh, 
1977) and with the concentration of OTA in human blood ( Hul t 
et al, 1982]. However, a direct causal relationship cannot be 
established on the basis of indirect evidence provided by the 
above retrospective studies alone. Neither can it be excluded 
in view of the long latency period between the exposure and 
the onset of syrnporns . 
1.1.2 Biological and biochemical activity 
OTA acts as a potent nephrotoxin in all animals 
invest.i.gated so far, including chickens, dogs, ducklings, 
6 
mice, rats, hens, sheep, swine and rainbow trout [WHO, 1979). 
Different species vary in their susceptibility to acute 
poisoning by OTA with LDso values ranging from 3. 4 to 34. 3 
mgjKg (Table 1} . 
When OTA was administered orally to rats, the kidney vias 
the target organ, but necrosis of periportal cells in the 
liver has also been noted during studies on acute effects 
[Purchase & Theron, 1968). 
The toxic effect of OTA is demonstrat Jd initially on the 
nephron; the proximal tubule is the primary target site. 
Change~ of renal function on OTA-exposed pigs and rats are 
characterized by impairment of proximal tubular function, 
indicated by a decrease of urine osrnolali ty, and by increased 
urinary excretion of proteins and glucose [Berndt et al, 
1980]. Based on the reported inhibition of transport of p-
aminohippurate (PAH} and tetraethylammonium in renal slices, 
it was proposed that OTA enters the proximal tubule cells by 
the common organic anion transport system [Sokol et al, 1988] • 
A particularly good correlation exists between the increase in 
the urinary excretion and decrease in renal activity of y -
glutamyl transferase (y-GT}, alkaline phosphatase (ALP) and 
leucine aminopeptidase (LAP) within a week after oral 
administration of 145~-Lg OTA/Kg body weight (bw) /day for 12 
weeks (Kane et al, 1986a] . Inhibition of gluconeogenesis was 
I 
1 
i • 
1 
7 
Table 1 
Acute toxicity of Ochratoxin A 
Animal LDso (mgjKg bw) Route of administration 
mouse (female) 22 intraperitoneal (i.p . ) 
rat (male) 30.3 oral 
rat (female) 21.4 oral 
rat (male) 28 oral 
rat (male) 12.6 i .p. 
rat (female) 14.3 i. p. 
guinea-pig (male) 9.1 oral 
guinea-pig (female) 8.1 oral 
white leghorn 3.4 oral 
turkey 5.9 oral 
Japanese quail 16.5 oral 
rainbow trout 4.7 i.p. 
pig (female) 6 (total dose) 1 oral 
[WHO, 1990] 
1Both pigs rece~v1ng 2 mg/Kg daily were moribund and killed 
within 3 days, and both pigs receiving 1 mg/Kg daily were 
moribund and killed with 6 days [Szczech et al, 1973]. 
8 
also observed in renal slices from rats fed with OTA 2mg/Kg bw 
for 2 days [Storen et al, 1982). Renal phosphenolpyruvate 
carboxykinase activity (PEPCK) was selectively lowered by 50%. 
This may be an early sign of OTA-renal damage. 
Suzuki et al. [1975] observed a 60% decrease in hepatic 
glycogen levels and a concomitant increase in serum glucose 
and blood and hepatic lactate levels in rats after daily 
administration of OTA 5 mg/Kg for 3 days. A single dose of 15 
mg/Kg bw decreased the activity of glycogen synthetase by 46% 
and increased the activity of phosphorylase by 40%. In vitro 
studies showed that OTA inhibited hepatic mitochondrial 
respiration primarily by altering the membrane permeability 
[Moore & Truelove, 1974]. 
Addition of OTA to renal cortical slices resulted in an 
increase in 45ca accumulation (Berndt et al, 1984]. Altered 
calcium homeostasis has been suggested as an event which might 
mediate cellular injury andjor death [Schanne et al, 1979]. 
It has been reported previously in our lab that in hepatic 
microsomes OTA strongly enhanced lipid peroxidation, and this 
led to an inhibition of calcium uptake [Khan et al, 1989; 
Rahimtula et al, 1988; Omar et al 1990]. 
OTA is a potent inhibitor of protein synthesis both in 
bacteria and mammalian cells. Studies have revealed that OTA 
competitively inhibits phenylalanyl-tRNA synthetase activity, 
which was proposed to be due to the phenylalanine moiety on 
9 
OTA [Creppy et al, 1984]. 
Carcinogenicity of OTA has been demonstrated in mice and 
rats, though OTA did not produce genetic or related effects in 
a variety of short term tests [Umeda et al, 1977; Wehner et 
al, 1978] • Long-term low dose feeding experiments, 
demonstrated that OTA is a hepatic and renal carcinogen in 
mice [Bendele et a.l, ,1985; Kanizawa & suzuki, 1978; Kanizawa, 
1984] . It has been reported that administration of OTA to 
male and female rats for up to 2 years caused uncommon tubular 
cellular adenomas and carcinomas of the kidney (Boorman 1988). 
OTA has also been shown to cause single strand breaks in DNA 
isolated from livers and kidneys of rats that had been fed the 
equivalent of 4ppm OTA for 12 weeks [Kane et al, 1986a&b]. 
OTA, when tested at 20 and 100 ~g/plate, did not have any 
effect in a Bacillus subtilis Rec-assay which measures DNA 
damage [Ueno & Kubota, 197 6] . Assays using a number of 
Salmonella typhimurium strains have not demonstrated bacterial 
mutagenicity with dose of OTA up to 1000 ~g/plate, with or 
without exogenous metabolic activation [Wurgler et al, 1991; 
Kuczuk et al, 1978; Wehner et al, 1978). Human exposure, as 
demonstrated by the occurrence of OTA in food, blood, and in 
human milk, has been observed in various countries in Europe 
[Gareis et al, 1988). Available epidemiological information 
indicates that Balkan nephropathy may be associated with the 
consumption of foodstuffs contaminated by this toxin. A 
10 
highly significant relationship has been observed between 
Balkan nephropathy and tumours of the urinary tract, 
particularly with tumours of the renal pelvis and ureters. 
However, no data have been published that establish a direct 
causal role of OTA in the etiology of such tumours. 
1.1.3 Absorption and metabolism 
In a study on rats exposed by gavage to a single dose of 
OTA at 10 mg/Kg bw, Galtier [1974b] found the highest tissue 
level of unmetabolized OTA in stomach wall during the first 
4 hr following administration. The small and large intestine 
and caecum contained small amounts of unchanged OTA, and it 
was concluded that OTA was absorbed mainly from the stomach. 
Small amounts of OTA (1-3% of the total d~se) were detected in 
the caecum and the large intestine, in the form of the 
isocoumarin moiety (OTa), most likely as the result of the 
hydrolysing action of the intestinal microflora [Galtier & 
Alvinerie, 1976; Hult et al, 1976]. In a study on intestinal 
absorption using the same animal species, Kumagai & Aibara 
[ 1982] came to the conclusion that the site of maximal 
absorption of OTA was the proximal jejunum. Lee and co-
workers [1984] studied the absorption and tissue distribution 
in Swiss mice over a 48-h period, after the administration of 
a single dose of 25 mg OTA/Kg body weight. The r esults 
.; 
.r 
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suggested that absorption mainly takes place in the duodenum 
and the jejunum. Recently, datd from our lab has shown that 
the OTA was absorbed mainly from the duodenum and the jejunum, 
although some absorption did occur in the stomach [Barrowman 
et al, 1993]. Absorption is largely dependent on the 
absorbing area of the organ. Since the small intestine has a 
larger surface area than the stomach, presumably more 
absorption would occur in the small intestine than in the 
stomach. 
In experimental studies on swine ingesting feed 
containing o•rA, residues of this toxin were found in all 
tissues investigated. In decreasing order of concentration, 
these were kidney, liver, muscle, adipose tissue [Krogh et al, 
1974]. A subsequent study revealed that the concentration of 
OTA residues in the blood of the pig was higher than those in 
the other tissues mentioned above [Mortensen et al, 1983]. 
When rats were exposed orally to an OTA dose of 10 mgjKg bw, 
Galtier (1974a] recovered 0.3% of the administrated dose in 
the whole kidneys, 0.9% in the whole liver and 0.6% in the 
total muscle tissue, 96 hr after exposure. In another 
experiment, using a single intraperitoneal injection of 1 mg 
OTA (labelled with 14c in phenylalanine) per rat, Chang and Chu 
[1977] found that the kidney contained twice as much unchanged 
OTA as the liver after 0.5 hr, amounting to 4-5% of the total 
dose. In the study by Lee et al (1984), the largest amounts 
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of OTA found in the kidney (as indicated by staining 
intensity) were in the epithelium of the proximal convoluted 
tubules, and to a lesser extent in the distal convoluted 
tubules, the descending loop of Henle, and glomeruli and 
Bowman's capsule. Using pig renal cortical slices [Friis et 
al, 1988), or canine renal brush border and basolateral 
membrane vesicles (Sokol et al, 1988], it was found that OTA 
enters the kidney via the renal organic anion transport 
system. 
OTA has been shown to bind to serum albumin by both in 
vivo and in vitro studies [Chang & Chu, 1977; Chu, 1971 & 
1974b; Galtier, 1974a). OTa has been detected in the urine 
and faeces of rats injected intraperitoneally with OTA [Nel & 
Purchase, 1968; Chang & Chu, 1977], indicating the cleavage of 
OTA to OTa and phenylalanine, under these conditions. Many 
environmental carcinogens and toxins require oxidative 
metabolism, most often by the cytochrome P-450 dependent 
monoxygenase system, in order to exert their toxic or 
carcinogenic effects [Miller & Miller, 1981]. In both albino 
and brown rats given OTA orally or intraperitoneally, 1-1.5% 
of the dose was excreted as ( 4R) -4-hydroxyochratoxin A and 25-
27% as OTa in the urine (Storen et al, 1982]. In in vitro 
studies using hepatic microsomes from the pig, rat, and man, 
both (4R)- and (4S)-4 - hydroxyochratoxin A were produced in a 
hydroxylation process involving cytochrome P-450 [Stormer & 
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Pedersen, 19BO: Stormer et al, 1981). OTA is known to be 
metabolized by rabbit hepatic rnicrosornes to an additional 
metabolite, 10-hydroxy-OTA [Ritchie & Idle, 1982]. 4-
Hydroxyochratoxin A is non-toxic to rats in amounts up to 
40mgjKg body weight [Hutchison et al, 1971 ) ; thus, it has been 
concluded that microsomal hydroxylation to this metabolite 
most likely represents a detoxification reaction. 
As mentioned above, OTA has been detected in the urine 
and some faecal samples of bacon swine and rats. OTA has also 
been shown to be present in the milk of rabbits and goats. In 
the former East Germany, a study of human milk obtained from 
women in two hospitals revealed that 11.1% contained OTA 
[Bauer & Gareis, 1987; Gareis et al, 1988). 
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1.2 Lipid peroxidation 
1.2.1 Lipid peroxidation 
Membranes in eukaryotes contain many essential 
polyunsaturated fatty acids (PUFA). A free radical (R·) which 
has sufficient energy to abstract a hydrogen atom from a 
methylene carbon of a membrane unsaturated fatty acid (LH) can 
initiate a chain reaction in bulk lipid. This reaction 
sequence is known as lipid peroxidation [Gutteridge, 1988]. 
Once the free-radical chain reaction is initiated, it 
propagates until the unsaturated lipid is exhausted or two 
free radicals destroy each other to terminate the chain. 
Lipid peroxidation reactions can be classified into three main 
stages, these are: initiation, propagation, and termination. 
Initiation: LH + R· -4 L" + RH (1.2.1) 
Propagation: L• + Oz .... Loo· (1.2.2) 
Termination: L• + L· .... LL (1.2.3) 
too· + too· -4 LOOL + Oz (1.2.4) 
too· + L" .... LOOL (1.2.5) 
where: R· = a free radical; LH = lipid 
t· = lipid radical; Loo· = lipid peroxy radical. 
If radical chain reactions are not terminated by the 
reaction of two radicals, they proceed concurrently, further 
destroying membrane lipid phase, especially lipid membrane. 
15 
In general, superoxide radicals and transition metal ions 
such as iron ions play a central role in the initiation of 
lipid peroxidation in biological systems. Ferrous ions are 
themselves free radicals and they can take part in electron 
transfer reactions with molecular oxygen: 
(1.2.7) 
Generation of oz· - by any source in the presence of ferrous 
ions can lead to the formation of hydroxyl radicals ("OH): 
20z"- + 2H+ .... HzOz + Oz 
Fe2• + HzOz -+ OH" + Fe3• + OH • 
(1.2.8) 
(1.2.9) 
It was previously shown (Omar et al, 1990; Hasinoff et 
al, 1990] that in a reconstituted system consisting of NADPH, 
the flavoprotein NADPH-cytochrome P-450 reductase and Fe2• 
ions, OTA s~imulates superoxide and hydroxyl radical formation 
in liver by the following reactions: 
E 011 + NADPH -+ Ercd + NADP+ 
Ered + Oz -+ Eox + Oz • -
20z·- + 2H• .... HzOz + Oz 
Fe3•-oTA + o 2 ·- -+ 0 2 + Fe2•-oTA 
Fe2• -OTA + HzOz .... OW + Fe3• -OTA + OH. 
(1.2.10) 
(1.2.11) 
(1.2.12) 
(1.2.13) 
(1.2.14) 
in which Eox and Ered are the oxidized and reduced froms 
respectively of NADPH-cytochrome P-450 reductase. The Fe3•-oTA 
complex is reduced very rapidly to Fe2•-oTA which, after 
binding to molecular oxygen, is transformaed to a reactive 
species that initiates lipid peroxidation. 
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The products of lipid peroxidation include lipid epoxy 
alcohols, epoxides, hydroperoxides and short chain compounds 
including malondialdehyde (MDA), ethane, pentane, and 4-
iroxy alkenals [Gutteridge, 1987; Kappus, 1985] (Fig. 2 & 
3). Malondialdehyde is the main defined reaction product 
measurable in a biological system which undergoes lipid 
peroxidation [Dahle et al 1962]. MD~ is commonly detected by 
the thiobarbituric acid (TBA) reaction, which is shown in Fig. 
4. The MDA-TBA complex is pink in colour, and has a absorbence 
at around 535nm. It is the most widely used method because of 
its simplicity and sensitivity. Ethane is another product. 
Measurement of ethane exhalation can be used as an in vivo 
indicator of lipid peroxidation, but a limitation of this 
method is that it does not identify the organ responsible for 
ethane production. It has been shown that the rate of ethane 
exhalation by rats treated with OTA was considerably higher 
than the ethane exhaled by control rats [ Rahimtula et al, 
1988]. This indicated that OTA stimulates lipid peroxidation 
in vivo, but it was not clear which organ(s) caused this 
elevation of lipid peroxidation. In addition, oxygen uptake 
can be measured as an indicator of lipid peroxidation in the 
cell, since oxygen is consumed to produce peroxy radicals 
during lipid peroxidation. Subsequent decomposition reactions 
of lipid peroxides can also consume oxygen. However, it is 
not as widely used as the MDA-TBA reaction. 
Fig. 2. Scheme representing the formation of ethane during 
lipid peroxidation induced by hydroxyl radicals 
[Kappus,l985] 
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Fig. 3. Scheme representing the formation of 
malondialdehyde during lipid peroxidation induced 
by ferrous-oxygen complexes or by hydroxyl radicals 
[Kappus, 1985] 
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Fig. 4. Chemical reaction of MDA-TBA formation 
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1. 2.2 Bio1ogical defence systems against lipid 
peroxldation 
The potential for generating oxygen radicals is great in 
biological systems. Thus 1 a number of defence systems exist 
to protect against oxygen radicals. These include many kinds 
of antioxidants and radical scavengers. The advent of 
oxidative stress in vivo often leads to increased levels of 
antioxidant •anzymes which serve to protect the organism/tissue 
from the deleterious effects of reactive oxygen species and 
lipid peroxidation products [Barros et al, 1991]. Superoxide 
disrnutase (SOD) rapidly catalyzes the dismutation of 0 2 • • to 
HzOz and Oz. catalase, a hacmoprotein, dismutates HzOz to o2 
and water. Hz02 if left intact can react with Fe2• to yield 
HO • radicals. Thus, the combination of SOD and catalase 
effectively el irninates the precursors of the very reactive and 
deleterious HO' radicals. Glutathione peroxidase, a Se 
containing enzyme, and glutathione reductase together with GSH 
(glutathione; y-glutailiylcysteinylglycine), are also involved 
in the removal of H20z: 
--------------+ 2H20 + GSSG 
GSH Peroxidase 
GSSG + NADPH + H+ -------------~ NADP+ + 2GSH 
GSSG Reductase 
Another enzyme, Glutathione s-transferase 1 is not directly 
involved in the removal of free radicals, but catalyses the 
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conjugation of an electrophilic xenobiotic with endogenous 
GSH. DT diaphorase catalyzes the oxidation of NADPH and NADH 
[Ernster, 1967). 
Vitamin E (a-Tocopherol) is one of the most pt3Werful 
antioxidants protecting membranes from peroxidative damage. 
The tocopherol moiety in Vitamin E reacts with lipid radicals, 
removes peroxy radic.J l, thereby breaking the radical chain 
reaction [Packer et al, 1979]. 
1.2.3 Cellular toxicity 
Lipid peroxidation has been implicated as a mechanism by 
which numerous organic chemicals produce toxicity. It is 
evident that lipid peroxidation reactions can destroy the 
biological membranes in which they occur. Plasma membranes of 
cells as well as intracellular membranes lose their 
ultrastructural architecture when cross-linking occurs between 
acyl chains, and long chain PUPA are depleted . These changes 
impair membrane fluidity and permeability [Bruch & Thayer, 
1983: Vladimirov et al 1980]. 
Lipid peroxidation also inactivates many enzymes and 
protein receptors, among which the best known are the loss of 
cytochrome P-450 [Hogberg et al, 1973) in microsornes, and the 
inactivation of membrane ca2•-ATPase (Waller et al, 1983]. 
This inactivation can be caused simply by loss of membrane 
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structure: the enzyme or the receptor undergoes conformational 
changes which result in activation or inactivation of the 
respective protein. For example, the membrane ca2•-ATPase is 
inactivated because of oxidation of essential sulfhydryl 
groups in the enzyme (Jones et al, 1983), resulting in 
jefective control of cytosolic calcium. 
Lipid peroxidation consumes amounts of oxygen, which may 
lead to a critical condition in cells where the oxygen supply 
is limited [Kappus, 1985]. It also leads to depletion of 
protective mechanisms involving antioxidants, glutathione, 
etc. 
In general, lipid peroxidation is a highly destructive 
process. Its specificity is low and it alters or destroys a 
great number of biornolecules. Cells, organs or whole 
organisms. lose structural architecture and/or biochemical 
functions. 
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~.3 Calcium homeostasis 
~.3.1 Introduction 
The important role of calcium in cellular function has 
been well recognized during the last decade. The involvement 
of calcium is mainly through: 1) maintenance of intracellular 
calcium homeostasis, and 2) regulation of cellular functions 
through the calcium messenger systems. 
The processes that regulate intracellular calcium are 
intricate, numerous, and diverse. Calcium homeostasis is 
maintained by a variety of transport systems in several 
different membranes: calcium gates, pumps, and channels 
operate to keep the free cytosolic calcium ion, (Ca2~] 1 , within 
a normal physiological range. Calcium homeostasis is also 
dependent upon the status of other cellular constituents, 
including sulfhydryls and glutathione (Johns et al, 1983). 
The calcium messenger system is a highly organized system 
which contains the signal system, the calcium receptor system, 
calcium homeostatic processes, and the calcium response system 
[Pounds, 1990). It has a central role in mediating many 
different cellular functions, which are generally of three 
types: cellular movement, including muscle contraction, 
amoeboid movement, and cytoskeletal functions; information 
processing, such as nerve impulse conduction and sensory 
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mechanisms: and the actions of hormones, including growth 
factors, on cellular growth and differentiation. Based upon 
the central role of the calcium messenger system in these 
aspects of cellular function, it is logical, if not 
inevitable, to examine possible disturbances in calcium 
homeostasis as underlying mechanisms of toxicant action. 
In addition, proximal cells are the major site of calcium 
reabsorption [Hook & Goldstein, 1992], and as mentioned 
before, the proximal tubule is the primary target of OTA. 
Thus, a disturbance in calcium homeostasis in the proximal 
tubule by OTA could play a role in its nephrotoxic effect. 
The extracelluar calcium concentration is about 0. 5 - 1. 3 
mM, and the intracellular free calcium concentration is close 
to 0.1 ~M, depending on the cell type [Dawson, 1990]. 
Maintenance of the concentration difference depends on two 
features of the plasma membrane: its low permeability to 
calcium and the presence of membrane-bound ATP-dependent pumps 
and Na+/CaZ+ exchangers that drive calcium out of the cell 
against the concentration gradient [Carafoli, 1987]. It has 
become increasingly clear in the last decade that this 
transport mechanism is tightly regulated, and that this 
regulation can affect the cytoplasmic (Ca~]. In addition, 
there are important internal, uptake-backflux systems 
associated with the sarcoplasmic reticulum (SR} in muscle 
cells, the endoplasmic reticulum (ER) .:! n non-muscle cells, the 
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mitochondrial inner membrane, secretory vesicles r and the 
membranes of other organelles. Among them, the ER was 
established as a major calcium storage site in ~~on-muscle 
cells (Somlyo et al, 1985]. Mitochondria are now generally 
considered not to play a major role in the cytosol ic 
homeostasis of calcium ( C."\rafoli 1987]. 
1.3.2 Endoplasmic reticular calcium transport 
The ER in non-muscle cells takes up calcium from the 
cytosol and releases it back, thereby contributing to the 
regulation of cytosolic calcium levels. Of the two processes, 
uptake and release, the former is much better understood. 
Though several pathways for the release of calcium have been 
described [Kraus-Friedmann, 1990], the exact physiological 
mechanism(s) responsible for the release of calcium are not 
fully understood. 
1.3.2.1 Calcium uptake 
The uptake of calcium by the ER i~ due to the activity of 
an ATP-dependent calcium pump. The pump is a high-affinity 
calcium ATPase, which interacts with calcium; but transports 
calcium with a low total capacity. The calcium ATPase is an 
El-E2 transport ATPase (Carafoli, 1987], which is postulated 
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to exist in two different conformational states El and E2 at 
different stages of the reaction mechanism, and to conserve 
the ATP energy intramolecularly in the form of an acyl 
phosphate, most likely an aspartyl phosphate (Fig. 5). The 
phosphoprotein intermediate in pig renal microsomes has a 
molecular mass of about 115 kDa [ Parys et al 1 1985], but this 
may vary in different cell types. 
calcium uptake is Mg2+-dependent 1 because MgATP is the 
substrate of the enzymatic reaction [Kraus-Friedmann 1 1990]. 
oxalate is the anion generally used to increase calcium uptake 
into the ER 1 as a result of its permeation into the lumen and 
the formation of an insoluble calcium complex (Parys et al 1 
1985, Heilmann et al 1 1984]. 
Microsomal calcium pump activity has been shown to be 
very sensitive to oxidative damage and lipid peroxidation 
[Waller et al, 1983], which may be due to the oxidation of 
essential sulfh~rdryl groups in the enzyme (Jones et al, 1983]. 
NADPH inhibits the ATP-dependent calcium pump of hepatic 
microsomes from rats [Prasad et al, 198 6]. It was proposed 
that the inhibition of calcium pump activity by NADPH is 
mediated by the direct oxidation of the critical pump protein 
thiol groups by the ferric-cytochrome P-450-oxygen pathway 
since GSH was found to reverse the inhibitory effect of NADPH 
[Holtzman et al, 1989, Srivastava, 1990] • These authors have 
suggested that activity of the microsomal calcium pump in vivo 
. , 
I 
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Fiq. s. Equation of ca-ATPase El.-E2 model [Carafoli, 1987] 
2C~:yt ATP 
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30 
is maintained by the cytochrome P-450 system which tends to 
oxidize sulfhydryls and thereby decrease activity: the enzyme 
thiol:protein disulfide oxidoreductase (TPDO) reduces these 
protein disulfides to reactivate the pump. The authors 
proposed that a specific isozyme(s) of cytochrome P-450 is 
responsible for the inhibition of the hepatic microsomal 
calcium pump and that a substrate or inhibitor for that 
particular isozyme would protect against NADPH inhibition of 
the calcium pump. Srivastava et al [1990] concluded that a 
few cytochrome P-450 isozymes, most likely members of the 
CYPIIB and CYPIIIA family, could be involved in the inhibitory 
effect. 
1.3.2.2 calcium backflux 
In contrast to the process of calcium uptake, which is 
the function of a single activity, that of the calcium-ATPase, 
the release of calcium from ER can occur in a multitude of 
ways. Of these, the release of calcium by the reversal of the 
calcium-ATPase is the best understood. This reaction was 
studied in the liver by Webb and Anders [1985] using calcium-
loaded microsomal vesicles. This preparation accumulated 
calcium in the presence of ATP to a maximal value. Upon the 
dilution of the calcium-loaded microsomal vesicles into a 
backflux medium, calcium release occurred, the rate of which 
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more than doubled upon the addition of ADP and P1• When 
studied under appropriate experimental conditions, the release 
of calcium was associated with the synthesis of ATP. 
Other ways by which calcium release can be evoked is by 
the addition of GTP or IP3 to calcium-loaded microsomal 
vesicles [Dawson et al, 1987]. Calcium release can also be 
caused by direct inhibition of the calcium-ATPase by GTP 
[Kimura et al, 1990). The most effective way of eliciting 
calcium release from the microsomal fraction so far identified 
is by the oxidation of critical -SH groups (Zhang et al, 
1990]. This mechanism is likely to be involved in the rise of 
cytosolic calcium observed in many instances of hepatocellular 
injury. 
1.3. 3 The role of calcium ions in the mechanism of toxic 
insults 
Because of the complexity and diversity of calcium 
homeostatic processes and calcium-mediated responses, it is 
useful to consider the many ways in which a toxicant may act 
on the calcium messenger system. Generally, calcium-related 
toxicity can be shown as a direct alteration of calcium 
homeos·tasis, andjor deregulation of calcium-mediatf.!d cellular 
functions. 
Toxicants may directly alter calcium homeostasis by 
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substituting for calcium at specific sites of calcium 
mobilization, transport, or storage; or by acting on specific 
cellular and molecular constituents of Ca2 ... -homeostatil.: 
processes, such as calcium pumps or gates, which may occur at 
molecular sites that are independent of, or remote from 
calcium, not at the calcium transport or binding site. Other 
divalent metals are commonly involved in substitution 
mechanisms, and the later type of interaction is observed with 
many organic toxicants. Toxicants that dissipate the Na+ 
gradient will secondarily alter calcium homeostasis in cells 
where the Ca2•;Na• exchange is a component of calcium 
homeostasis. Na+ transport is affected by numerous drugs, 
thiol status, and energy metabolism. Toxicants may 
secondarily alter calcium homeostasis through non-specific 
effects on cellular function that are biochemically and 
functionally remote from the processes of calcium transport 
and storage, such as altered calcium permeability and 
transport properties of the membrane [Michaelis, 1983). 
The acute toxicity of organic toxicants has been linked 
to altered calcium homeostasis [Schanne et al, 1979; Moore, 
1982; Orren ius et al, 1989] • The exposure of hepatocytes to 
~Cl4 and certain other halocarbons, carbon disulfide, or 
thioacetamide results in rapid loss of ca2+-ATPase activity and 
loss of the ability of the endoplasmic reticulum to sequester 
calcium (Moore et al, 1976; Lowrey et al, 1981; Long & Moore, 
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1986; Tsokos-Kuhn, 1989]. Other toxicants such as cisplatin 
may increase renal ca2•-ATPase activity (De Witt et al, 1988). 
Maintenance of normal (Ca~) homeostasis is also dependent 
upon the status of other cellular constituents, including 
sulfhydryl status and GSH (Johns et al, 1983]. Agents that 
cause oxidative stress, or which deplete cellular glutathione 
through conjugation reactions will perturb calcium fluxes and 
intracellular compartmentation resulting in deregulation of 
cellular function and cell death [Johns et al, 1983; Orrenius 
et al, 1984]. 
In our lab, it has previously been shown that OTA 
administration to rats increased ethane exhalation (an index 
of in vivo lipid peroxidation) (Rahimtula et al, 1988] and 
inhibited the hepatic microsomal calcium pump activity [Khan 
et al, 1989]. Also, OTA addition to hepatic microsomes in the 
presence of NADPH greatly enhanced lipid peroxidation and 
strongly depressed microsomal calcium uptake. Moreover, a 
good correlation was observed between inhibition of ATP-
dependent calcium uptake and enhanded lipid peroxidation as 
judged by MDA formation [Khan et al, 1989]. However, the 
effects of OTA on calcium homeostasis need to be examined in 
great detail. 
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1.4 Objective of the thesis 
The objective of my research is to investigate the effect 
of in vivo OTA administration to rats on renal cortical (i) 
microsomal calcium pump activity, (ii) lipid pero::ddation and 
(iii) cytosolic antioxidant enzyme levels. The effect of in 
vitro addition of OTA to renal cortical microsomes on calcium 
uptake and lipid peroxidation is also examined. The purpose 
of these experiments is to establish the importance (if any) 
of lipid peroxidation in OTA-induced alteration in renal 
microsomal calcium uptake. 
These studies are considered relevant in view of the fact 
that OTA is primarily a nephrotoxin and previous studies have 
uhown that ( i) administration of OTA to rats resulted in 
enhanced lipid peroxidation in vivo as evidenced by increased 
ethane exhalation (Rahimtula et al, 1989], ( ii) OTA stimulated 
NADPH-dependent lipid peroxidation in hepatic microsomes in 
vitro [Rahimtula et al, 1989; Omaret al, 1990], and (iii) OTA 
inhibited hepatic microsomal calcium uptake both in vivo and 
in vitro [Khan et al, 1989]. 
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CHAPTER 2 
2. MATERIALS AND METHODS 
2 .1 Materials 
2.1.1 Chemicals 
ATP, butyl a ted hydroxytoluene ( BHT) , 1-butanol, dimethyl 
sulfoxide ( DMSO) , ethylenediamine tetracetic acid-disodiurn 
salt (EDTA) , NADPH, ochratoxin A (OTA), 2-thiobarbituric acid 
(TBA) , xanthine, 2 1 5-dichlorophenol indophenol ( DCPIP) 1 Tween-
20, 1-chloro-2,4-dinitrobenzene (CDNB) (recrystallized from 
ethanol) 1 dicoumarol, reduced glutathione (GSH) , oxidized 
glutathione (GSSG), ferricytochrome c, and xanthine oxidase 
were purchased from Sigma Chemical Co. (St. Louis, MO, 
U.S.A.). 45CaClz (specific activity 16.1 rnCijmg) was purchased 
from Du Pont Canada Inc. (Montreal, Que. , Canada) , and [ y-32P] 
ATP (specific activity 5 1 000 Cijmrnol) was purchased from 
Amersham Canada Limited (Oakville, ont., canada). All ether 
chemicals were of the highest grade commercially available. 
2.2 Methods 
2.2.1 Animal treatment 
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Male Sprague-Dawley rats (225 - 300 g) were obtained 
from Charles River Canada, La Prairie, Quebec and maintained 
on standard laboratory rat chow and water ad lib. OTA was 
administered intraperitoneally (i.p.) or orally (p.o.) as a 2 
mgjmL solution in 0.1 M sodium bicarbonate. 
treatments are listed below: 
The various 
1) OTA {0.5, 1, 2, or 4 mg/Kg bw), i.p. daily for four days, 
2) OTA (0.5, 1, or 2 mgjKg bw), i.p. daily for eight days, 
3) OTA (5 mg/Kg bw) as a single dose, 
4) OTA (10 mg/Kg bw), i.p. as a single dose, 
5) OTA (10 mg/Kg bw), p.o. as a single dose. 
Control rats received an equivalent amount of vehicle (0.1 M 
sodium bicarbonate) . Each animal was anaesthetized with ether 
and the blood was taken from the abdominal aorta at the 
indicated times after treatrneut, then a cut was made up 
through the diaphragm and both kidneys were excised and 
weighed. Renal cortical microsomes were prepared as described 
in 2.2.2. 
2.2.2 Preparation of microsomes 
Rat renal cortical microsornes were isolated from 
untreated or OTA-pretreated rats. All the following 
procedures were performed at o - 4°C according to the method 
described by Rahimtula et al [1979]. The kidneys from each 
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rat were excised and pooled separately (unless specially 
indicated) in ice-cold 0.1 M potassium phosphate buffer (pH 
7. 4) . The kidneys were then sliced in half and the cortex was 
carefully cut off from the medulla with scissors. The renal 
cortex was minced into fine pieces and homogenized in J 
volumes (w/v) of 0.1 M potassium phosphate buffer (pH 7.4) by 
a motor-driven Potter-Eljevhem homogenizer. In some cases, 2 
mL of the homogenate was taken, mixed with EDTA (final 
concentration 1 rnM) , and stored for lipid peroxide measurement 
using MDA-TBA method. The rest of the homogenate was 
centrifuged at 10,000 x g for 15 min. 
Microsomes were isolated from the 10,000 x g supernatant 
by centrifugation at 105,000 x g for 75 min. In some cases, 
the 105,000 x g supernatants (cytosol) were stored at -70~ 
for up to one week before used for measurement of enzyme 
activities. The microsomal pellets were resuspended by 
homogenization in 0.1 M phosphate buffer (pH 7.4) in a volume 
equal to the initial weight of the renal cortex (to yield a 
protein concentration of about 10 mg/mL). 
For MDA measurement, EDTA (final concentration 1 mM) was 
added to 1. 5 mL of the microsomal suspensions which were 
stored separately. All samples were stored at -70~ for up to 
one week before used. Protein concentration was determined by 
the method of Lowry et al [1951), using bovine serum albumin 
as a standard. 
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2.2.3 In vitro preincubations 
Prior to measuring calcium uptake, cortical microsomes 
(1.0 mg proteinjrnL) from control rats were preincubated with 
NADPH (0.75 mM) in the presence or absence of OTA. For OTA 
concentration studies, renal cortical microsomes (1.0 mg 
proteinjmL) were preincubated in 0.1 M potassium phosphate 
buffer (pH 7.4) for 10 min at 37°C with a range of OTA 
concentrations (0 to 1.0 mM: added in a maximum of 5 ~L of 
DMSOjmL incubation volume) in the presence or in the absence 
of NADPH (0.75 mM). 
For the time course, renal cortical microsomes (1.0 mg 
proteinjmL) were incubated as above with OTA (1 mM) but for 
various time periods (2 min to 1 hr). At the end of the 
incubation, the mixtures were immediately cooled on ice and 
centrifuged at 105,000 x g for 30 min at 4°C to recover the 
microsomes. The supernatants were discarded and the 
microsorn~l pellets obtained were resuspended in imidazole-
histidine buffer (30 mM imidazole, 30 mM histidine, 100 mM 
KCl; adjusted to pH 6.8 with imidazole) to a concentration of 
0.5 mg protein/mL and assayed for calcium uptake as described 
below in 2.2.4 . 
Microsomal calcium transport 
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Measurement of calcium uptake 
Calcium uptake activity by renal cortical microsomes from 
control or OTA-adrninistered rats or in in vitro incubated 
rnicrosomes was measured by the method of Moore et al [1976]. 
Microsomes (0.1 to 0.15 mg proteinjmL) were added to the ice-
cold imidazole-histidine buffer containing 5 mM MgC12 , 5 mM 
ATP, 5 mM ammonium oxalate, 20 J.LM cacl2 and 0.1 J.LCi/mL 45cacl2 • 
A 0.5 mL aliquot was filtered immediately with the aid of a 
vacuum apparatus on pre-wetted glass rnicrofibre filters 
(Whatman, type 934-AH; diameter 24 rnrn; pore size 0.2 ~rn) as 
zero time. The reactions were then started by placing the 
tube.s in a 37°C shaking-water bath and at indicated time 
intervals, 0.5 mL aliquots were withdrawn and filtered in the 
same way as described above. After rapid washing with 10 mL 
of ice-cold buffer, individual filters ~ere placed in separate 
scintillation vials and air dried. Bound radioactivity was 
monitored in a Beckman LS-1801 liquid scintillation counter 
after addition of 5 mL scintillation fluid (ScintiVerse II*, 
Fisher Chemical Co.). 
For studies on the direct effect of OTA on cortical 
rnicrosornes, OTA (O to 1.0 mM) was added to the system at the 
indicated time points. 
To monitor the effects of calcium concentration on the 
calcium uptake activity, rnicrosornes (0.1 to 0.15 mg 
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proteinjmL) were added to the same system described above but 
containing different amounts of CaClz (0.5 to 100 ~M) instead 
of the standard 20 ~M CaClz. The specified concentrations of 
ca2• refer to amounts of this metal added to the incubations 
and does not take into account the already existing Ca~ in the 
membrane. 
To show that the microsomal calcium uptake under these 
conditions is ATP-dependent, i.e. is due to a calcium ATPase, 
ATP was omitted from the system in specified experiments. 
2.2.4.2 Determination of [ATP] during calcium uptake 
Incubation Microsomes were preincubated with NADPH in 
the presence or absence of OTA (1 mM) for 10 min, centrifuged 
and the resuspended microsomes were incubated for calcium 
uptake as described in 2. 2. 4 .1, except that CaC12 was used 
instead of 45CaC12 • At timed intervals, 0.5 mL aliquots were 
withdrawn and mixed immediately with 2 mL of 0.6 M HC104 to 
stop the reaction. The samples were brought to a pH of -6.5 
by addition of 4 mL of 0.1 M potassium phosphate (pH 7.5) and 
o. 3 mL 30% KOH. The precipitated KCl04 was removed by 
filtering through a 0.45 ~ nylon filter (Cameo II, MSI, 
Westboro, MA) and ATP levels were measured in the filtrate by 
HPLC as described below. 
Chromatographic conditions HPLC conditions were as 
.. , 
'· 
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described by Stocchi et al [1987) with some modification. 
The HPLC system used was a Perkin-Elmer Series 4 Solvent 
Delivery system, a Model ISS-100 Auto-Injector, a Model 3600 
Data Station, and an LC detector. ATP/ADP analyses were 
performed on a 5 ~m Supelco LC-18 Reversed Phase analytical 
column (4.5 mm x 24 em) protected with a LC-18 guard column 
(4.5 mrn x 5 em) (Bellefonte, PA). The injection volume was 20 
~L. The mobile phase used for the separation of nucleotides 
consisted of two buffers: 0.1 M potassium phosphate, pH 6.0, 
containing 8 mM tetrabutylammonium hydrogen sulfate (buffer A) 
and 0.1 M potassium phosphate, pH 6.0, containing 8 mM 
tetrabutylammonium hydrogen sulfate and 30% (vjv) of methanol 
(buffer B). 
The analyses were performed at room temperature with a 
flow rate of 1. 5 mL/rnin and detection at 254 nrn. The 
chromatographic conditions used were as follows: 
Time (min.) % A 
0-2.5 100 
5.0 80 
10 60 
13-18 0 
18.1-22 100 
The system was calibrated by injecting standard ATP/ADP 
solutions of known concentration. Initially, a 4-level 
calibration run was performed, giving a linear response 
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(standard curve) for standard ATP/ADP. 
2.2.4.3 Measurement of calcium backflux 
Microsomes ( 3 mg protein/mL) from control rats were 
loaded passively by incubating for 2 hr at 0-4°C in 100 mM 
KCl, 5 rnM MgC12, 20 mM HEPES, pH 7. 5 with 1 mM 45CaC12 (0. 7 
J.LCi) in a total volume of 2. 0 mL. Efflux of 45ca2• was 
measured as described by Tsokos-Kuhn et al [1989) and 
initiated by diluting 100 J.LL of this mixture (in triplicate) 
into 2.9 mL of ice-cold buffer containing 100 mM KCl, 5 rnM 
MgClz, 20 mM HEPES, 2 mM EGTA, pH 7.5 with different 
concentration of OTA at 0-4 °c. At timed intervals, 0. 5 mL 
aliquots were taken, filtered and washed in the same way as 
described in 2.2.4.1. 
2.2.5 Measurement of lipid peroxidation 
Lipid peroxidation in the samples was monitored by 
measuring the level of the MDA as described by Uchiyama and 
Mihara [1978). In a 10 mL test tube, 0.5 mL (about 5 rng 
protein) of homogenate or microsomes was mixed with 3 mL of 1% 
H3P04 to keep the pH of the medium at about 2. 0. One 
millilitre of o. 6% aqueous TBA was then added and the mixture 
was heated at l00°C for 45 min. After cooling, 4 mL of 1-
·! 
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butanol was added and the mixture was shaken vigorously. The 
butanol phase was separated by centrifugation and its 
absorbance at 535 and 520 nm was measured. The difference in 
absorbance at these two wavelengths was taken to avoid 
interference due to the protein [Uchiyama & Mihara, 1978]. 
Tetramethoxypropane was used as an external standard to 
calculate the MDA-TBA value as MDA is released by the 
hydrolysis of tetramethoxypropane. The level of MDA-TBA is 
expressed as nmol of MDA per mg protein. 
Phosphorylation of ER vesicles 
Protein phosphorylation levels were measured by labelling 
microsomes with (y-32P]ATP followed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) analysis as 
described by Heilmann [1984, 1985, 1989] with some 
modification. Phosphorylation was carried out at 0°C in a 
volume of 0.2 mL and contained 37 rnM Hepes (pH 6.8), 0.1 M 
KCl, 50 J.LM CaC12 , 2.5 rnM azide, 1.85-7nM [y-32P]ATP (specific 
radioactivity 5,000 Ci/mmol), and 30 ~g microsomal protein. 
The reaction was stopped after 1 min by addition of 0.2 mL of 
a solution containing 8% SDS (W/v), 10% 2-mercaptomethanol 
(vjv) and 188 mM Tris- HCl (pH 6.8). Samples were incubated 
for 15 min at 37°c and them mixed with 50 J.LL of 100% sucrose. 
SDS-PAGE was carried out by the method of Laernmli (1970] as 
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described by Spamer et al (1987]. Proteins were stained with 
coomassie Brilliant Blue R-250 to distinguish the bands. 
Destained gels were dried by heat under vacuum and exposed to 
Kodak x-omat RO film. The protein band corresponding to the 
[~P]phosphorylated protein (Mr 116,000) was then cut, 
solubilized with 0.25 mL of 30% H20 2 at 50°C and bound 
radioactivity was quantified by 1 iquid scintillation counting. 
Measurement of enzyme activities 
2.2.7.1 catalase 
catalase activity of cytosol was estimated by measuring 
the decrease in absorbance of H2o 2 at 240 nrn (20°C). The assay 
was carried out in 3 mL of 50 rnM potassium phosphate buffer 
(pH 7) containing 0.1 mg protein/mL cytosol and 0.02% H2o 2 • 
The reaction , ... as ~tarted by addition of H20 2 (mixed well with 
a plastic paddle) and absorbance was recorded for about 30 sec 
[Aebi, 1984] . The molar absorbency of H2o 2 is 43.6 M"1 • cm"1• 
2.2.7.2 superoxide dismutase (SOD) 
Enzyme activity was measured by a modification of the 
method described by McCord and Fridovich [1969]. The assay 
was performed in 3 mL of 50 mM potassium phosphate buffer (pH 
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7.8) containing 100 ~M EDTA in a thermostated cuvette at 25°C. 
The reaction mixture contained 10 ~M ferricytochrome c, 100 ~M 
xanthine, and 0.015-0.02 units xanthine oxidase to produce a 
rate of reduction of ferricytochrome c at 550 nm of o. 025 
absorbance unit per min. Addition of cytosol reduced the rate 
of cytochrome c reduction in proportion to its SOD content and 
the decreased rate of absorbance change was recorded. Under 
these defined conditions, the amount of SOD (cytosol) required 
to inhibit the rate of reduction of cytochrome c by 50% is 
defined as 1 unit of activity. 
2.2.7.3 Glutathione peroxidase 
Glutathione Peroxidase activity was measured as described 
by Lawrence and Burk (1976]. The reaction system contained in 
a total volume of 1 mL: 50 mM potassium phosphate buffer (pH 
7.0), 1 mM EDTA, 1 mM NaN3 , 0.2 mM NADPH, 1 E.U. GSSG-
reductase, 1 mM GSH, and 0.25 mM H202. All ingredients except 
enzyme source (cytosol) and peroxide were combined at the 
beginning of each day. cytosol (0.1 mL) was added to o.s mL 
of the above mixture and allowed to incubate for 5 min at room 
temperature before initiation of the reaction by the addition 
of 0.1 mL of 2.5 rnM H2o2 • The rate of decrease i n absorbance 
at 340 nm was recorded for 5 min and glutathione peroxidase 
activity was calculated from the slope of these lines as ~mol 
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NADPH oxidized per min. Blank reactions with enzyme source 
replaced by distilled water were subtracted from each assay. 
2.2.7.4 Glutathione reductase 
Glutathione reductase activity was assayed 
spectrophotometrica11y in a reaction mixture containing 50 mM 
potassium phosphate buffer (pH 7.6), 0.1 rnM NADPH, 0.1% bovine 
serum albumin (BSA) and 3.3 mM GSSG in a final volume of 1 mL. 
The reaction was started by adding cytosol (1.0 mg protein), 
and was followed by recording the rate of reduction of NADPH 
at 340 nm [Flohe & Gunzler 1984]. The extinction coefficient 
of NADPH is 6. 22x103 M" 1• cm· 1• 
2.2.7.5 Glutathione S-transferase 
Glutathione s-transferase activity was measured as 
described by Habig et al (1974] using ~-chloro-2,4-
dinitrobenzene (CDNB) as acceptor substrate. The reaction 
mixture contained 0.1 M potass ~ um phosphate buffer {pH 6.5), 
1 mM GSH, 1 mM CDNB and cytosol (0.1 mg protein) in a total 
volume of 3 mL. The reaction was started by adding GSH, and 
the absorbence was followed at 340 nm. 
coefficient of CDNB is 9. 6x103 M"1• cm·1 • 
The extinction 
1 j 
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D'l' diaphorase 
DT diapho:--ase was assayed spectrophotornetrically by a 
modified method of Ernster ( 1967]. The reaction mixture 
contained 25 mM Tris-HCl buffer (pH 7.5), 0.2 rnM NADPH, 40 mM 
2,6-dichlorophenolindophenol (DCPIP), 10 ~M dicournarol, 0.07% 
BSA and o. 001% Tween-20 in a final volume of 3 mL. The 
reaction was started by the addition of 0.1 mg cytosolic 
protein, and DCPIP reduction was recorded at 600 nm (25°C). 
The extinction coefficient of DCPIP is 2 .1x104 M" 1 • cm· 1 • 
2.2.8 statistical Analyses 
Data were analyzed by the Student's 11 t 11 test or ANOVA 
when the multiple comparisons were done. The Benferroni test 
as post test was used in ANOVA to correct the "P" value 
obtained in the "t" test. The level of significance was taken 
as p<O. 05 or p8<0. 05 for the "t" test or the Benferroni test, 
respectively. 
. '· 
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C H A P T E R 3 
3. Results 
3.1 Biological observations on OTA treated rats 
It was observed that 4 or 8 days after the multiple low 
dose OTA treatment or 12 hr after a single high dose OTA (10 
mgjKg, i.p.) treatment, the treated rats had an accumulation 
of fluid in their abdominal cavity. 
Rats in some groups were weighed both before and after 
the treatment. Fig. 6 shows that after 4 days of treatment, 
rats in the control group gained weight of about 42%, from 
184.5 g to 262.5 g (p=0.0003); but the gain of weight in OTA 
( 4 mg/Kg, i. p. , daily) treated group was not significant (from 
193.8 g to 206.0 g). Comparing the weight gained in the two 
groups (78 g in the control group and 12.2 g in the treated 
group), the difference was significant (p=0.0005). S i nce the 
control rats were much bigger than the treated ones, it was 
not a surprise that their liver weights (10.28 g) were 
significantly higher (p=o. 001) than those in the treated 
groups (7. 05 g) . In Table 2, values of the percentage of 
liver weight over body weight are shown, and there is no 
difference between the control (3.91 g) and treated (3.43 g) 
groups of the 4-day treatment. The weight of the kidneys in 
the 4-day treatment groups showed no difference between the 
' ! 
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control and treated groups (Fig. 6) , but the percentage weight 
of kidneys over body weight (0.75% bw) in the treated group 
were significantly {p=0.0091) higher than those (0.64% bw) in 
the control group. 
Fig. 7a shows that after 8 days treatment, the weight of 
the rats dropped by about 22% (p=0.0059) in the 2 mgjKg OTA 
(i.p., daily) group (from 233.3 g to 181.3 g), and remained 
unchanged in the two lower dose groups, but increased by about 
19% (p=0.0325) in the control group (from 232.7 g to 277.0 g). 
Comparing the weight gained/lost in the control and OTA 
treatment groups after the 8 days (Fig. 7a), the difference 
was significant (p<O. 05) . The liver weights were lighter 
(p8<0.05, ANOVA test) in the treated groups (about 10 g) than 
in the control group (about 12 g), but there was no difference 
observed in kidneys weights (Fig. 7b). Values of the 
percentage of liver/kidneys weight over body weight did not 
show any difference between control and the two lower dose 
groups, but the values of the 2 mgjKg dose group were 
significantly higher than those of the control group (Table 
2). In the 2 mg/Kg dose group, the percentage of liver weight 
over body weight ( 5. 86%) was significantly higher than that in 
the control group (4. 76%), and the percentage of kidneys 
weight over body weight (1.1%) was significantly higher 
(0.82%) than that in the control qroup. 
. ' ' 
Fig. 6. comparis-:>n of body, liver and kidneys weights 
between control rats and OTA treated rats after 
tour days treatment. 
Rats were treated with OTA ( i. p., 4. 0 rng/Kg) or 
vehicle (bicarbonate) daily for 4 days, and weighed 
before and after the treatment. The liver and both 
kidneys were wiped dry and weighed. 
* denotes a significant (p=O.OOOJ) difference in 
weight 
** denotes a significant \p=O.OOl) difference in 
weight 
*** denotes a significant (p=O.OOOS) difference in 
weights gained between the control and treated 
rats. 
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Fig. 7a. Changes in rat body weight after eight days of OTA 
treatment. 
Fig. 7b. Comparison of liver and kidneys weights between 
control and OTA treated rats (8 days). 
Rats were treated with OTA (i.p., 0.5, 1.0, 2.0 
mg/Kg) or vehicle (bicarbonate) daily for 8 days, 
and weighed before and after the treatment. The 
liver and both kidneys were wiped dry and weighed. 
* denotes a significant (p=0.0325, t test) 
difference in weight 
** denotes a significant (p=0.0095, t test) 
difference in weight 
*** 
denotes a significant (Pa<O. 05, AN OVA test) 
difference in weight gcdned between the 
control and the treated rats. 
**** 
denotes a significant ( Pa<O. 05, AN OVA test) 
dif _:· erence in weight 
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Table 2 
Kidney & Liver weight as percentage of body weight 
•rreatment Kidneys Liver 
% bw % bw 
4 aays 
1. Control 0.639±0.039 3.910±0.179 
2. OTA ( 4mg/Kg) 0.753±0.045* 3.428±0.423 
8 days 
1. Control 0.820±0.040 4.757±0.167 
2. OTA (0.5mg/Kg) 0.792±0.007 4.233±0.319 
J. O'l'A ( lmg/Kg) 0.848±0.006 4.687±0.165 
4. OTA (2mg/Kg) 1. 100±0. 03 5*** 5.863±0.142** 
* denotes a significant difference (p=0.0091, t test) 
** denotes a significant difference (p8<0.0l, ANOVA test) 
*** denotes a sjgnificant difference (p8<0.001, ANOVA test) 
~ · 
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3.2 Role of lipid peroxidation 
3. 2 .1 Lipid peroxidation in renal cortical homogenates 
and microsomes isolated from control and OTA 
treated rats 
To monitor the lipid peroxidation, MDA levels were 
measured in renal homogenates and microsomes {Tables 3 & 4) 
prepared from control rats and rats dosed with OTA. As 
compared to controls, there was no significant change in MDA 
levels in either cortical homogenates or microsomes isolated 
from rats pretreated with o. 5 mg/Kg to 4 mgjKg OTA, i. p., 
daily for 4 days, or 0.5 mgjKg to 2 mg/Kg OTA, i.p., daily for 
8 days. However, the MDA levels in cortical homogenates 
prepared from rats treated 30 min and 2 hr earlier with OTA ( 5 
mg/Kg, i.p.) were 0.30 and 0.44 nmoljmg protein, which are 
significantly lower than the MDA level of o. 57 nmoljmg protein 
in cortical homogenates from control rats. A significant 
decrease from 0. 58 nmoljmg protein to o. 4 6 nmoljmg protein was 
also observed in the cortical homogenates prepared from rats 
treated 2 hr earlier with OTA (10 rng/Kg, i.p.) as compared to 
controls. However, there was no change in the 10 min (10 
rng/Kg, i.p.) treatment group. 
56 
Table 3 
Effect of a single dose of OTA on renal malondialdehyde levels 
Treatment 
Control (sol vent, lh) 
5 mg/Kg (30 min) 
5 mg/Kg (2 h) 
Control (sol vent) 
10 mg/Kg ( 10 min) 
control (sol vent) 
10 mg/Kg (2 h) 
MDA ( nmoljmg 
homogenate 
0. 57±0. 14 
0. 30±0. 02 1*** 
0. 44±0. 04 1** 
2 0. 51±0. 04 
2 0. 52±0. 05 
2 0. 58±0. 07 
0. 46±0. 02 2* 
protein) 
micro somes 
0.47+0.03 
0.47±0.04 
0.46+0.01 
0.40+0.03* 
Rats were treated with either solvent. or OTA (i.p.). MDA 
levels were measured in whole homogenate or cortical 
homogenate or cortical microsomes as described in 2. 2. 5. 
Values shown are means ± s. D. of duplicate determinations from 
3 individual rats per treatment group. 
whole homogenate; 2 cortical homogenate 
* denotes a significant difference (p<O. 02, t test) 
** denotes a significant difference (p8<0. 05, ANOVA test) 
** 
denotes a significant difference (pa<O. 001, ANOVA test) 
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Table 4 
Effect of multiple doses of OTA on renal rnalondialdehyde 
levels 
Treatment 
Control (solvent) 
0.5 mg/Kg (daily for 4 days) 
1 mgjKg (daily for 4 days) 
2 mgjKg (daily for 4 days) 
control (solvent) 
4 mgjKg (daily for 4 days) 
control (solvent) 
0.5 mg/Kg (daily for 8 days) 
1 mgjKg (daily for 8 days) 
2 mgjKg (daily for 8 days) 
MDA (nrnoljmg protein) 
homogenate microsornes 
0.25±0.06 
0.26±0.03 
0.25±0.01 
0.29±0.04 
0.23±0.02 0.39±0.07 
0.23±0.04 0.44±0.04 
0.82±0.05 0.60±0.02 
0.71±0.01 0.65±0.06 
0.64±0.08 0.57±0.04 
0.80±0.06 0.56±0.02 
Rats were treated with either solvent or OTA (i.p.). MDA 
levels were measured in cortical homogenate or cortical 
microsornes as described in 2 . 2. 5. Values shown are means ± 
S.D. of duplicate determinations from 3 individual rats per 
treatment group. 
Fig. 8. :rnhibi tion of NADPH-dependent lipid peroxidation by 
OTA. 
Microsornes were pre-incubated with varying 
Lipid concentrations of OTA + NADPH for 10 min. 
peroxidation was measured in the recovered 
microsomes by determining the levels of MDA as 
described in 2.2.5. 
of two experiments 
triplicate. 
Va 1 ues shown are means ± S. D. 
(n=2), each performed in 
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In vitro effect of OTA on renal cortical microsomal 
lipid peroxidation 
The in vitro results (Fig. 8) are consistent with the 
reduced or unaltered MDA levels measured in renal cortical 
homogenates or microsomes after in vivo treatment. In the 
presence of NADPH, MDA levels were 2. 2 5, 1. 83, 0. 48 and 0. 33 
nmoljmg protein with 0, 0.25, 0.5, 0.75 and 1.0 mM OTA 
respectively (Fig.B). Very little MDA was formed (< 0.2 
nmoljmg protein) at the end of the incubation in the absence of 
NADPH. In this experiment, MDA levels were measured in 
parallel with calcium uptake (3.3.4 & Fig. 26) in microsomal 
incubations carried out in the presence of NADPH alone or 
NADPH along with varying concentrations of OTA. The results 
indicate that the observed dose-dependent reversal of NADPH 
inhibition of calcium uptake by OTA correlates well with the 
decrease in 1 ipid peroxide levels as measured by MDA 
formation. 
3.2.3 studies on the protective system~ against lipid 
peroxidation 
The occurrence of oxidative stress in vivo often results 
in increased levels of a variety of antioxidative enzymes 
(Barros et al, 1991). Therefore, the levels of a variety of 
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cytosolic enzymes subsequent to treatment of rats with OTA 
were measured. The results of the 4 day treatment are shown 
in Table 5. The levels of GSSG reductase and superoxide 
disrnutase (SOD) were not significantly altered from the 
control values of 194.4 nrnol GSSG reduced and 7. 8 units, 
respectively. Glutathione s-transferase activity was 445.3 
nrnol CDNB conjugated in cortical supernatants of the control 
rats, and dropped by about 12% (to 393.8 nrnol CDNB conjugated, 
p 8<0.05) and 21% (to 353.2 nmol CDNB conjugated, p9<0.01) in 
rats pretreated daily for 4 days with o. 5 mg, and 1 mg OTA/Kg 
respectively. The activity remained unchanged in the 2 mg/Kg 
and 4 mg/Kg dose groups. GSH peroxidase activity was 229.1 
nrnol H202 in cortical supernatants of control rats, and 
declined by about 2 6% (to 168. 8 nmol H2o2 reduced, p 8<0. 01) and 
31% (to 158.7 nmol Hz02 reduced, p9<0.01) in cortical 
supernatants of rats pretreated daily for 4 days with 1 rng, 
and 2 mg OTA/Kg respectively. The activity remained unchanged 
in the o. 5 and 4 mgjKg dose groups. The levels of catalase 
were unaltered except in the 1. 0 mg/Kg dose group, where a 29% 
drop (from 55.5 to 39.5 J.Lmol, p8<0.001) was observed. The 
specific activity of DT-diaphorase was similarly reduced by 
about 26 to 38% (from 85.4 nmol to 58.9, 62.5 and 52.7 nmol in 
the o.s, 1.0 and 2.0 mg/Kg doses groups respectively, 
p 8 <0. OS) , except in the 4. o mgjKg group where no reduction in 
the activity was observed. 
Table s 
Effect of multiple OTA dosing (4 days) on activities of some antioxidant enzymes 
Assay conditions are as described in 2.2.7. Values shown are means + S.D. of 
quadruplicate incubations from 3 individual rats per treatment group. 
~moljminjmg protein 
2 
3 
4 
5 
6 
* 
** 
** 
nmol H202 reduced/minjmg protein 
nmol GSSG reduced/minjmg protein 
nmol CDNB conjugated/min/mg protein 
unitjminjmg protein, (SOD - superoxide dismutase) 
nmol DCPIP reducedjminjmg protein 
denotes a significant difference (p8<0.05, ANOVA test) 
denotes a sjqnificant difference (p8 <0.01, ANOVA test) 
denotes a significant difference (p8<0.0D1, ANOVA test) 
OTA treatment (mgjKg, i.p., daily) 
Enzyme Activity 0 0.5 1.0 2.0 4.0 
*** Catalase1 55.5+0.4 56.4+1.2 39.5+0.6 57.3+2.4 
•• ** GSH peroxidase2 229.1+29.4 202.9+8.6 168.8+2.8 158.7+8.6 
GSSG reductase3 194.4+25.7 199.4±9.1 184.8+11.4 186.9+8.4 
* ** 
GSH s-transferase4 445.3+11.0 393.8+8.2 353.2+13.2 440.6+39.8 
soo5 7.8+1.2 8.9+0.1 8.4+0.4 8.5+0.1 
** * ** DT-diaphorase6 85.4+8.3 58.9+7.4 62.5±7.6 52.7+7.6 
catalase1 87.2+8.2 98.5+9.5 
GSH peroxidase2 146.7+9.9 162.4+15.6 
GSSG reductase3 139.2+7.7 137.4+6.8 
GSH S-transferase4 338.1·.-)5.6 370.0±28.1 
SOD5 15.0+1.1 16.3+0.9 
DT-diaphorase6 41.8+8.1 41.5+4.1 
Table 6 
Effect of multiple OTA dosing (8 days) on activities of some antioxidant enzymes 
Assay conditions are as described in 2.2.7. Values shown are means + S.D. of 
duplicate incubations from 3 individual rats per treatment group. 
~moljmin;mg protein 
2 
3 
4 
5 
6 
** 
** 
nmol H20 2 reducedjminjmg protein 
nmol GSSG reduced/minjmg protein 
nmol CDNB conju~atedjminjmg protein 
unitjminjmg protein, (SOD - superoxide dismutase) 
nmol DCPIP reducedjminjmg protein 
denotes a significant difference (p8<0.05, ANOVA test) 
denotes a significant difference (p8<0.0l, ANOVA test) 
denotes a significant difference (p8<0.001, ANOVA test) 
OTA treatment (rng/Kg, i. P• I daily) 
Enzyn:e Activity 0 0.5 1.0 2.0 
** *** *** Catalase1 49.4+2.0 36.5+8.1 28.5+0.1 17.3+0.8 
GSH peroxidase2 219.2+42.6 194.9+31.2 241.1+22.9 221. 2+28. 5 
GSSG reductase3 102. 5+11. 3 95.5+1.4 113.8+15.6 101.5+12.8 
* ** GSH S-transferase4 265. 5+21. 04 222.7+5.5 237.5+17.7 199.0+36.7 
SOD5 8 . 5+0.4 8.3+0.3 8.2+0.2 8.5+0.1 
DT-diaphorase6 91.1+7.4 82 . 2+8.2 96.4+5 . 1 101. 1:!:,9. 5 (" 
\. :-' 
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The results of the 8 day treatment groups are shown in 
Table 6. There were no changes in the activities of GSSG 
reductase, GSH peroxidase, SOD, and DT-diaphorase. The 
activity of GSH s-transferase decreased significantly 
(p8 <0.05) from the control value of 265.5 nmol CDNB conjugated 
to 222.7 and 199.0 in the 0.5 mg/Kg and 2.0 mg/Kg dose groups, 
respectively. The decrease of enzyme activity in the 1. 0 
mgjKg dose group (237.5 nmol CDNB conjugated) was not 
statistically significant. The catalase activity dropped 
significantly from the control value of 49.4 ~mol to 36.5 
~mol in the 0.5 mg/Kg dose group (p8<0.01), 28.5 ~mol in the 
1 mg/Kg dose group (p8<0.001), and 17.3 ~mol in the 2 mg/Kg 
(p8<0.001) dose group. 
3.3 Rat renal cortical microsomal calcium pump studies 
3.3.1 The effect of a single high dose of OTA on renal 
cortical microsomal calcium pump activity 
Administration of a single high dose of OTA (10 mgjKg; 
i.p.) resulted in a significant elevation of ATP-dependent 
calcium pump activity in renal cortical microsomes. Figs. 9 
to 13 show the rate of calcium uptake by renal cortical 
Fiq. 9. Calcium uptake by renal cortical microsomes 
isolated from control rats and rats treated with 
OTA 10 min earlier (10 mgjKg i.p.). 
Calcium uptake measurements were carried out in 
imidazole-histidine buffer (pH 6.8) containing 0.1 
- 0.15 mg/mL microsomal protein, 5 mM MgCl 2 , 5 mM 
ammonium oxalate, 5 mM ATP, 20 ~M CaClz, and 0.1 ~ci 
45caClz. At the indicated times, 0. 5 mL al iquots 
were filtered through glass microfibre filters. 
The filters were washed with ice cold imidazole-
histidine buffer, and bound radioactivity 
determined as an index of calcium uptake by 
microsomes. Details are described in 2.2.4.1. 
Microsomes from individual rats were assayed twice, 
each time in triplicate. Values shown are means ± 
s.o. from 4 individual rats (n=4). 
* denotes a significant difference (p~O.Ol) from 
control. 
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Fiq. 10. Calcium uptake by renal cortical microsomes 
isolated from control rats and rats treated 2 hr 
earlier with OTA (10 mg/Kq i.p.). 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individual rats were assayed twice, 
each time in triplicate. Values shown are means + 
S.D. from 5 individual rats. 
* denotes a significant difference (pso.005) 
from control. 
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Fig. 11. Calcium uptake by renal cortical microsomes 
isolated from control rats and rats treated 6 hr 
earlier with OTA (10 mg/Kg i.p.). 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individual rats were assayed twice, 
each time in triplicate. Values shown are means + 
S.D. from 6 individual rats. 
* denotes a significant difference (p~0.05) from 
control. 
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Fig. 12. Calcium uptake by renal cortical microsomes 
isolated from control rats and rats treated 12 hr 
earlier with OTA (10 mg/Kg i.p.). 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individual rats w~re assayed twice, 
each time in triplicate. Values shown arc means ± 
S.D. from 4 individual rats. 
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Fiq. 13. Calcium uptake by renal cortical microsomes 
isolated from control rats and rats treated 24 hr 
earlier with OTA (10 mqjKq p.o.). 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individual rats were assayed twice, 
each time in triplicate. Values shown are means + 
S.D. from 6 individual rats. 
* denotes a significant difference (p~0.05) from 
control. 
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microsomes isolated from rats treated 10 min, 2 hr, 6 hr, and 
12 hr earlier with OTA (10 mg/Kg, i.p.) or 24 hr earlier with 
OTA (10 mg/Kg, p.o) or vehicle. The rate of calcium uptake 
was linear for about 20 min but continued to increase 
throughout the 40 min incubation. The elevation of calcium 
uptake was apparent within 10 min of OTA administration 
(i.p.). The rate of calcium uptake increased from about 21 
nmol/20 min in the control group to about 34 nmol/20 min in 
the OTA dose group (Fig. 9). A mi~ximal increase (p<0.005) of 
about 80% (from 25 to 45 nmol/20 min) was observed after 2 hr 
of OTA administration (Fig , 10). The increase (from 35 
nmol/20 min to 50 nmol/20 min, p<0.05) could still be observed 
at 6 hr (Fig.11). However, by 12 hr, there was no significant 
difference between the control and OTA treated groups (Fig. 
12). In the p.o. treated rats, a significant increase 
(p<0.05) in the rate of calcium uptake (from 49 to 55 nmol/20 
min) was observ~d 24 hr after the treatment (Fig. 13). 
3.3.2 The effect of multiple low doses of OTA on renal 
cortical microsomal calcium pump activity 
A mixed response was observed after multiple dosing of 
rats with OTA. Lower doses of OTA elEwated the rate of 1\TP-
dependent calcium uptake while higher doses depressed it. 
' • • -r 
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Administration of 1 or 2 mgjKg, i. p. daily for 4 days 
increased the rate of calcium uptake to 22 nmolj20 min in the 
1 mg/Kg dose group and ~o 17 nmol/20 min in the 2 mgjKg dose 
group as compared to 12 nmol/20 min in tho control group 
(Figs. 15 & 16). An increase in calcium uptake was also 
observed in the 0. 5 mgjKg dose group but this was not 
significant (Fig. 14) . Daily dosing with o. 5 mgjKg and 1 
mgjKg for 8 days did not alter the calcium pump activity 
(Figs. 18 & 19). In contrast, daily dosing with 2 mgjKg 
(i.p.) for 8 days and 4 mgjKg (i.p.) for 4 days resulted in a 
decrease of the calcium uptake activity of 48% (from 44 
nmol/20 min to 23 nmol/20 min} to 50% (from 38 nmol/20 min to 
19 nrnol/20 min), respectively (Figs. 17 & 20). 
3. 3. 3 The in vitro direct effect of OTA on renal cortical 
microsomal calcium pump activity 
In jn vitro studies, the presence of OTA in the 
incubation mixture during calcium uptake strongly inhibited 
the uptake reaction. 
Fig. 14. Calcium uptake by renal cortical microsomes 
isolated from control rats and rats treated with 
OTA (0.5 mgjKq, i.p.) daily for 4 days. 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individual rats were assayed twice, 
each time in triplicate. Values shown are means + 
S.D. from 4 treated or 6 control rats. 
* denotes a significant difference (p~0.05) from 
control. 
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Fiq. 15. calcium uptake by renal cortical microsomes 
isolated from control rats and rats treated with 
OTA (1.0 mqjKg, i.p.) daily for 4 days. 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individual rats were assayed twice, 
aach time in triplicate. Values shown are means ± 
S.D. from 6 control or 4 treated rats. 
* denotes a significant difference (p<O.Ol) from 
control. 
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Fig. 16. calcium uptake by renal cortical micro somes 
isolated from control rats and rats treated with 
OTA (2.0 mg/Kg, i.p.) daily for 4 days. 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individual rats were assayed twice, 
each time in triplicate. Values shown are means + 
S.D. from 6 control or 4 treated rats. 
* denotes a significant difference (p~0.02) from 
control. 
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Fig. 17. calcium uptake by renal cortical microsomes 
isolate~ from control rats and rats treated with 
OTA (4.0 mg/Kg, i.p.) daily for 4 days. 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individual rats were assayed twice, 
each time in triplicate. Values shown are means ± 
S.D. from 6 individual rats. 
* denotes a significant difference (p50. 0001) 
from control. 
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Fiq. 18. Calcium uptake by ~enal cortical microsomes 
isolated from control rats and rats treated with 
OTA (0.5 mq/Rq, i.p.) daily for a days. 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individu~l rats were assayed twice, 
each time in triplicate. Values shown are means + 
S.D. from 5 individual rats. 
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Piq. 19. Calcium uptake by renal cortical microsomes 
isolated from control rats and rats treated with 
OTA (1.0 mqjKq, i.p.) daily for 8 days. 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individual rats were assayed twice, 
each time in triplicate. Values shown are means ± 
S.D. from 5 individual rats. 
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Fig. 20. Calcium uptake by renal cortical microsomes 
isolated from control rats and rats treated with 
OTA (2.0 mgfKg, i.p.) daily for a days. 
Calcium uptake was measured as described in Fig. 9. 
Microsomes from individual rats were assayed twice, 
each time in triplicate. Values shown are means ± 
S.D. from 5 individual rats. 
* denotes a significant ditference (p<O.OOOl) 
from control. 
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The calcium uptake rate of 65 nmol at 20 min of incubation in 
the absence of OTA dropped by 65% (to 23 nmol), 77% (to 15 
nmol) or 98% (to 1.5 nmol) in the presence of 0.25 mM, 0.5 mM 
or 1 mM OTA, respectively (Fig. 21). This inhibitory effect 
of OTA was both rapid and (at least partially) reversible. 
The effect was rapid because addition of OTA (0.5 rnM) 5 or 10 
min after calcium uptake was initiated, resulted in an 
inhibition of calcium uptake similar to that observed if OTA 
had been present at the start of the incubation (Fig. 22). 
The effect appeared to be reversible because, in comparison to 
direct addition (Fig. 21), pre-incubation of microsomes with 
0.25 mM, 0.5 mM or 1 rnM OTA for 10 min followed by 
centrifugation, led to only a 18%, 35% or 54% inhibition of 
calcium uptake respectively from the control value of 44.5 
nmolj40 min in recovered microsomes incubated in the absence 
of OTA (Fig. 23). 
3.3.4 
3.3.4.1 
The in vitro effect of OTA on renal cortical 
microsomal calcium uptake in the presence of NADPH 
NADPH-dependent calcium uptake 
In an effort to determine if mixed function oxidase 
(MFO)-dependent metabolism of OTA alters its effect on 
Fiq. 21. Inhibitory effect of in vitro OTA addition on 
calcium uptake by ren~l cortical microsomes. 
Calcium uptake was measured as described in Fig. 9 
but in the presence of various concentrations of 
OTA. Values shown are means + S.D. of two 
experiments, each performed in triplicate. 
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Fiq. 22. Effect of delayed addition of OTA on ca1cium uptake 
by cortical microsomes. 
Calcium uptake was carried out as in Fig. 9 except 
that OTA was added at o min, 5 min or 10 min after 
the start of the reaction. Values shown are means 
± S.D. of two experiments, each performed in 
triplicate. 
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Fig. 23. Inhibition of calcium uptake by pre-incubation of 
microsomes with NADPH and its reversal by OTA. 
Cortical microsornes were pre-incubated for 10 min 
with the indicated concentrations of OTA in the 
presence or absence of NADPH. Subsequent to 
centrifugation, calcium uptake by the recovered 
rnicrosomes was determined as described in Fig. 9 
except that only the 40 min point was taken. 
Values shown are means ± S.D. of two experiments, 
each performed in triplicate. 
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calcium uptake, NADPH was also included in the incubation of 
medium. Calcium uptake was measured in parallel with MDA 
(3.2.2, Fig. 8) in microsomes pre-incubated with varying 
concentrations of OTA alone or in the presence of NADPH. 
Results shown in Fig. 23 indicate that pre-incubation of 
microsomes with NADPH strongly suppressed their ability to 
sequester calcium (by about 92%, from 44.5 nrnol/mg protein to 
3.7 nmoljmg protein). However, inclusion of OTA during pre-
incubation with NADPH resulted in a partial concentration-
dependent re·..rersal of this inhibitory effect. Thus. the 
microsomes pre-incubated with 1 rnM OTA and NADPH appeared to 
have a 5 to 10 fold "higher" rate of calcium uptake than that 
observed in microsornes pre-incubated with NADPH alone. 
Fig. 24 shows the effect of pre-incubation time with OTA 
( 1 mM) in the presence of NADPH on the alterations of 
microsomal calcium pump activity. The "stimulatory" effect of 
OTA was most significant in 10 min pre-incubated microsornes 
(about 6. 3-fold) , while the "stimulatory" ef feet was 5. a-fold, 
5. 2-fold and 3. 6-fold in 2 min, 30 min and 60 min pre-
incubated microsomes, respectively. 
Piq. 24. Effect of varyinq preincubation times of cortical 
microsomes with OTA (1 mM) and NADPH on subsequent 
calcium uptake activity. 
Cortical microsomes were pre-incubated for 2 to 60 
min with OTA in the presence of NADPH. Subsequent 
to centrifugation, calcium uptake by the recovered 
microsomes was determined as described in Fig. 9 
except that only the 4 o min point was taken. 
Values shown are means + S.D. of two ~xperirnents, 
each performed in triplicate. 
* denotes a significant difference (p8<0. 05, 
ANOVA). 
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ATP-dependent calcium uptake by rat renal cortical 
microsomes 
Calcium uptake by rat renal cortical microsornes pre-
incubated with NADPH in the presence or absence of OTA was 
always measured with ATP present ( 5 mM) • In order to 
demonstrate the dependence of calcium uptake on ATP, the 
later was ami tted from two of the incubations in this 
experiment. Fig. 25 shows that in the presencP of ATP, OTA 
strongly "stimulated" calcium uptake by abr-•Jt 5-fold (from 1. 5 
to 8 nmol/20 min), but in the absence of ATP there was almost 
no calcium uptake by either control or OTA pre-incubated 
microsomes. 
3.3.4.3 oxalate-dependent ca~cium uptake by rat renal 
cortical microsomes 
Oxalate is normally used to enhance calcium uptake in 
hepatic microsomes, as a result of its permeation into the 
lumen and the formation of an insoluble calcium complex (Parys 
et al, 1985; Heilmann et al, 1984]. This experiment was set 
up t.o demonstrate the enhancement of calcium uptake by oxalate 
it: renal microsomes. The results show (Fig. 26) that in the 
control samples in the presence of NADPH, the renal cortical 
microsome calcium uptake in the absence of oxalate was much 
Fiq. 25. Role of ATP on renal cortical microsomal calcium 
uptake. 
Calcium uptake was measured as described in Fig. 9 
in the presence or absence of ATP. Values shown 
are means ± s. D. of two experiments, each performed 
in triplicate. 
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Fiq. 26. Role of ammonium oxalate on renal cortical 
microsomal calcium uptake in the presence of NADPH 
± OTA. 
Calcium uptake was measured as described in Fig. 9, 
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(5 rnM). Values shown are means ± S.D. of two 
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lower (0.2 nmol/20 min) than that in the presence of oxalate 
(1.5 nmol/20 min). Also, in the samples pre-incubated with 
OTA in the presence of NADPH, calcium uptake in the absence of 
oxalate was much lower (3.8 nmol/20 min) than that in the 
presence of oxalate (8.4 nmol/20 min). In both cases, with 
and without oxalate, the calcium uptake was significantly 
"enhanced" by OTA. 
3.3.4.4 Dependence of calcium uptake on calcium ion 
concentration 
Fig. 27a shows that calcium uptake "stimulated 11 by OTA in 
the presence of NADPH was dependent on the calcium ion 
concentration. Fig. 27b shows the double reciprocal plot 
(Lineweaver-Burk plot) [Armstrong, 1983) of 1/V vs. l/[Ca2•]. 
The two intercepts on the vertical axis were different, which 
indicates that the Vrnax of the reaction was altered by OTA. 
However, the two intercepts on the horizontal axis were the 
same indicating that the Km of the ATPase for calcium was not 
changed by OTA. 
3.3.5 The effect of OTA on the levels of the 
phosphoenzyme intermediate 
In the presence of calcium, addition of (y-32P]ATP to 
Fig. 27a. Dependence of calcium uptake on the concentration 
of ca2•. 
Fig. 27b. Double Reciprocal Plot (Lineweaver-Burk Plot) of 
Fig. 27a. 
Calcium uptake was measured as described in Fig. 9, 
but with the various concentration of cacl2 • Values 
shown are means ± S.D. of two experiments, each 
performed in triplicate. 
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hepatic microsomes is followed by rapid formation of the 
phosphorylated enzyme intermediate [Spamer et al, 1987]. The 
results show that alterations in the rate of calcium uptake 
brought about by in vivo/in vitro OTA treatments correlated 
well with the levels of the phosphoenzyme intermediate (Table 
7). Thus, OTA administration which led to an increased rate 
of ATP-dependent microsomal calcium uptake also showed a 
.. 
··' 
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Table 7 
Effect of OTA on phosphorylation of renal rnicrosornes 
Treatment [32p] bound 
In vivo 
1. Control 
2. OTA (10mg/Kg, i. p. , 2hr) 
Control 3. 
4. OTA (4mg/Kg daily for 4 days) 
1. 
2. 
3. 
4. 
In vitro 
Control (- NADPH) 
+ NADPH 
OTA {lmM) 
OTA (lmM) + NADPH 
(nrnol/mg 
Expt 
0.7 
1.7 
7.0 
2.9 
1.2 
0.3 
0.6 
0.8 
protein X 106 ) 
1 Expt 2 
0.6 
1.5 
5.8 
2.5 
1.4 
0.2 
0.7 
0.6 
Microsomes were labelled with [ y-32P] ATP and subjected to SDS-
PAGE ~s described in 2. 2. 6. 
separate experiments are shown. 
Individual values from two 
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higher level of the phosphoenzyme intermediate (1.6 x 10"6 
1 •• nol) as compared to control microsomes (0.65 x 10"6 nmol). 
conversely, reversal by OTA of the NADPH-dependent 
inhibition of calcium uptake was also accompanied by a 
simultaneous increase in the leVel of the phosphoenzyme 
intermediate (from o. 25 x 10·6 nmol to o. 7 x 10"6 nmol) . 
3.3.6 The role of calcium backflux in the effect of OTA 
on renal cortical microsomes 
The net rate of calcium uptake by the ER is the 
difference between the rate of calcium uptake and the calcium 
release (backflux) by the ER membrane. Thus, an alteration in 
the calcium backflux rate by OTA could contributf; to the 
difference in calcium uptake rates observed in the presence of 
OTA. However, addition of OTA (up to a concentration of 1 mM) 
to microsomes loaded with 45ca did not significantly alter the 
rate of calcium backflux (Fig 28). 
3.3.7 ATP consumption during calcium uptake 
Since calcium uptake is dependent on the presence of ATP, 
it was important to demonstrate that an inhibition of calcium 
uptake was not due to premature depletion of ATP. Hence, ATP 
consumption during calcium uptake was measured in order to 
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determine if the added ATP was sufficient for calcium uptake. 
The results show that at the end of the incubation (40 min), 
up to 35% of ATP was consumed in the OTA/NADPH addition group, 
and about 10% of ATP was used in the NADPH control group (Fig. 
29) • 
3.3.8 The effect of OTA analogues on renal cortical 
microsomal calcium pump activity 
Different OTA analogues - Ochratoxin B (OTB, de-chloro 
OTA); Ochratoxin c (OTC, methyl ester of OTA); and Ochratoxin 
a (OTa, isocumarin part of OTA) , were used in vitro to examine 
their effects on calcium uptake activity in order to 
characterize the importance of the chlorine atom, the free 
carboxyl group and the Phenylalanine moiety, respectively (see 
Fig. 1 for structures). 
Fig. 30 shows the effect of 1 rnM OTA, OTB, OTC, and OTa 
on calcium pump activity in NADPH-preincubated rnicrosomes. 
OTA gave the highest "stimulation" of calcium uptake, about 7-
fold as compared to NADPH alone (from 2. 0 to 15.0 nrnoljmg 
protein), followed by OTC (about 2-fold; from 2.0 to 4.4 
nmol/mg protein), while OTa and OTB were ineffective. 
Fig. 28. Effect of OTA a~~ition on rates of calcium 
backflux. 
Microsomes passively loaded with ecacl2 were 
incubated in KCl-MgC1 2-HEPES-EGTA buffer (pH 7.5) in 
the presence of various concentrations of OTA. ht 
timed intervals, 0.5 mL aliquots were filtered, 
washed and bound radioactivity determined as 
described in 2. 2. 4. 3. Values shown are means + 
S.D. of two experiments, 
triplicate. 
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Fig. 29. consumption of ATP during calcium uptake by 
microsomes pre-incubated with NADPJ• in the presence 
and absence of OTA. 
Microsomes were pre-incubated with NADPH ± OTA ( 1 
rnM) for 10 min and the centrifuged microsomes were 
incubated as described under calcium uptake (Fig. 
9) except that 45cacl2 was ami tted. At timed 
intervals, 0.5 mL aliquots were withdrawn for 
determination of ATP levels by HPLC as described in 
2.2.4.2. Values shown are means ± S.D. from one 
experiment performed in quadruplicate. 
Fig. 30. The effectiveness of OTA analogues (1mM), OTB, OTn, 
and OTo: in reversing the inhibitory effect of NADPH 
on renal cortical microsomal calcium uptake. 
Experiments were carried out as described in Fig. 
15 in the presence of NADPH except that OTB, OTC or 
OTa were used instead of OTA. Values shown are 
mean ± S.D. of two experiments 
performed in triplicate. 
(n=2) , each 
120 
18 
* ,.......... .~ 16 
Q) 
• control 
D OTC 
~ 
0 14 
L 
!S:sl OTA 
0.. f22l OTa 
CJ) 12 
E ~ OTB 
......... 10 
0 
E 8 c 
~ 
Q) 6 
.::f. 
0 * 
-+-1 
0. 4 
:J 
+ C'l 
0 2 
u 
0 
121 
C H A P T E R 4 
4. Discussion 
4.1 Lipid peroxidation studies 
The advent of oxidative stress in vivo often leads to 
increased levels of antioxidant enzymes which serve to protect 
the organismjtissue from the deleterious effects of reactive 
oxygen species and lipid peroxidation products [Barros et al, 
1991; Kappus, 1985, Fisher, 1988]. However, the results show 
that there is neither an induction of any antioxidant enzymes 
(Table 5 & 6) nor increased levels of lipid peroxides in the 
kidney subsequent to OTA adminstration (Table 3 & 4) under a 
variety of treatment conditions. In fact, significant 
decreases in some enzyme activities and in MDA levels were 
observed in kidneys of rats treated 30 min to 2 hr earlier 
with OTA. Also, in in vitro incubations of renal cortical 
rnicrosomes with OTA, MDA levels were suppressed (Fig. 8). 
This suggests that OTA might not produce significant 
quantities of free radicals in renal rnicrosomes in vitro or in 
vivo in the kidney during the early stages of treatment. This 
does not rule out lipid peroxidation as a contributory 
mechanism to OTA nephrotoxicity under conditions of chronic 
exposure. However, it appears that lipid peroxidation 
probably does not play a role during the early stages of OTA 
i 
• . 
) 
, I 
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nephrotoxicity. The difference in the values between the two 
control studies (Table 5) may be due to the varying conditions 
of the rats from batch to batch, which is also the reason why 
proper control studies were done in every experiment. 
4.2 ER calcium pump studies 
The data provide evidence that administration of a single 
high dose or multiple lower doses of OTA is associated with an 
increase in renal cortical microsomal ATP-dependent calcium 
pump activity. The increase in microsomal ATP-dependent 
calcium pump activity occurs within the first 10 min after OTA 
administration (i.p.) and lasts for at least 6 hr. A similar 
increase was also observed 24 hr after a oral dose of OTA. 
Earlier time points were not examined. The delayed reaction 
may be due to the fact that OTA is absorbed more slowly when 
administrated orally than intraperitoneally. 
It has been shown that calcium uptake by renal cortical 
slices was substantially enhanced within 5 min of OTA addition 
[Berndt et al, 1984]. As the endoplasmic reticulum (ER) is 
considered to represent the major calcium pool inside the cell 
that maintains calcium homeostasis [ Cara fol i, 1987], the 
increase in ER calcium uptake activity observed subsequent to 
in vivo OTA treatment may be a response to an increase in the 
cytosolic Ca2• concentration in order to help restore calcium 
123 
homeostasis. 
Based on the results shown in Fig. 25, it can be said 
that calcium uptake measured under the incubation conditions 
is indeed ATP-dependent. When oxalate was present in the 
medium, calcium uptake was more significant than in its 
absence (Fig. 26). These results are in good agreement with 
what Moore et al (1976] observed, and thus provided a 
reasonable framework for setting up the experimental 
conditions. 
The increase in renal cortical ER ATP-dependent calcium 
pump activity is the earliest enzymatic change thus far 
reported in the kidney after OTA administration. De Witt et 
al [1988) observed a similar increase in renal endoplasmic 
reticular calcium uptake activity within 4 hr after 
administration of cisplatin. 
However, repeated administration of moderate doses of OTA 
(4 mg/Kg, i.p., daily for 4 days) or lower dose of OTA (2 
mg/Kg, i. p., daily for 8 days) eventually resulted in a 
decrease in the rate of calcium uptake, which may be due to 
the dysfunction of calcium ATPase, and could lead to even 
higher cytosolic calcium concentrations that may further 
accelerate cell death. 
The microsomal calcium pump activity has been shown to be 
very sensitive to oxidative damage and lipid peroxidation 
(Waller et al., 1983). Rahimtula et al [1988) have previously 
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reported that OTA administration to rats increased ethane 
exhalation (an index of in vivo lipid peroxidation) and 
inhibited the hepatic microsomal calcium pump activity [Khan 
et al, 1989] . Also, OTA addition to hepatic microsomes in the 
presence of NADPH greatly enhanced lipid peroxidation and 
strongly depressed microsomal calcium uptake., Moreover, a 
good correlation was observed between inhibition of ATP-
dependent calcium uptake and lipid peroxidation as judged by 
MDA formation [Khan et al, 1989]. The increase in the rate of 
calcium uptake by renal cortical microsomes was observed soon 
after OTA dosing ( 10 min) suggesting that OTA probably does 
not induce lipid peroxidation in the early stage of its 
nephrotoxicity. This is in agreement with data showing that 
no increase in lipid peroxida~ion was observed (3.2). 
In in vitro experiments, GTA itself inhibited the renal 
microsomal calcium uptake, but partially reversed the 
inhibition caused by NADPH. Prasad et al [ 1986] previously 
observed a similar inhibitory effect of NADPH on rat hepatic 
microsomal calcium uptake activity and proposed that it is 
mediated through a cytochrome P-4 50 pathway, in which an 
oxygenated cytochrome P-450 complex directly oxidized critical 
protein thiol groups since GSH was found to reverse the 
inhibitory effect of NADPH. They suggested that activity of 
the microsomal calcium pump in vivo is maintained by the 
cytochron~~ P-450 system which tends to oxidize sulfhydryls and 
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thereby decrease activity while the enzyme thio protein 
disul.fide reductase reduces these protein disulfides to 
reactivate the pump [Holtzman et al, 1989]. On the assumption 
that, if a substrate is metabolized by a particular isozyme ( s) 
of cytochrome P-450, then its addition should compete for the 
activated oxygen complex and reverse the NADPH inhibition of 
the calcium pump, Srivastava et al [ 1990] concluded that 
several cytochrome P-450 isozymes, most likely members of the 
CYPIIB and CYPIIIA farnil.y, could be involved in the inhibitory 
effect. Possible involvement of the CYPIIB family in the 
reversal of the inhibitory effect of NADPH by OTA is 
consistent with the results of Hietanen et al [1.986] who 
showed that phenobarbital pretreatment of rats induces OTA-4-
hydroxylase activity. If OTA serves as a substrate for the 
particular cytochrome P-450 isozyme (s), it would compete for 
the active enzyme oxygen complex, thus reducing the latter's 
ability to induce lipid peroxidation and inactivate the 
calcium pump, i.e., OTA would seem to activate the calcium 
pump. The observation that in vitro OTA only increased the 
Vmax but not the Km for calcium uptake (3.3.4.4, Fig. 27b) 
would be consistent with the above. 
In the presence of calcium, addition of [y-32P] ATP to 
hepatic microsomes is followed by rapid formation of the 
phosphorylated enzyme intermediate (Sparner et al, 1987). The 
level of phosphorylated enzyme intermediate has direct 
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relationship with calcium pump activity. Our results 
indicated that changes in the rates of renal microsomal 
calcium uptake correlated with changes in the steady-state 
levels of the phosphorylated Mg2•;ca2•-ATPase intermediate. 
OTA administration which led to an increased rate of ATP-
dependent microsomal calcium uptake also showed a higher level 
of the phosphoenzyme intermediate as compared to control 
microsomes (Table 7). Thus, it suggests that in vivo/in vitro 
conditions were affecting the rate of enzyme phosphorylation, 
which in turn was affecting the calcium uptake level by 
altering the amount of activated enzyme. 
The calcium backflux experiments (Fig. 28) 1 which showed 
no alteration in the rate of calcium backflux after addition 
of OTA, indicated that alterations in calcium backflux were 
not responsible for the change of calcium uptake. similarly, 
differences in the rate of ATP consumption can not account for 
the increased rates of calcium uptake observed after OTA 
administration in vivo or OTA/NADPH addition in vitro. The Km 
for ATP in renal microsomes was found to be 3.1 mM [Moore et 
al, 1974] 1 thus the increase in calcium uptake in the presence 
of OTA probably was an under estimation. However, this should 
not affect the overall stimulating effect of OTA on calcium 
uptake, since the differences in calcium uptake can be 
observed within 10 min when more than 4. 3 mM of ATP was still 
available in the incubation (Fig. 29). As proximal cell is 
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the major site of calcium reabsorption, the altered calcium 
homeostasis may be the reason why proximal tubule is the 
primary target site of OTA toxic effect. 
The study of the effect of OTA analogues on the calcium 
pump activity indicated that OTA is the most effective of all 
the compounds tested in "stimulating" renal cortical calcium 
uptake. OTC was next with about 1/3 the activity of OTA 
( 3. 3. 8, Fig. 30) . OTB and OTa were very poor in "stimulating" 
calcium uptake. From this study 1 it can be inferred that the 
presence of a free carboxyl group is important since its 
blockage by esterification, as in OTC, substantially reduced 
the ability of effecting calcium uptake. The inability of OTB 
to affect calcium uptake is 1 ikely due to the absence of the 
chlorine atom which is known to alter the pKa of the phenolic 
hydroxyl [Chu, 1974a]. L-phenylalanine also appears to be a 
key moiety of OTA since OTa did not show any effect on calcium 
uptake. How exactly these different groups affect calcium 
uptake is not known at present. 
The inhibitory effect of OTA alone on calcium uptake in 
vitro could possibly be due to its ability to disrupt the 
integrity of the microsomal membrane. OTA is known to bind 
tightly to proteins. Chu [ 1971] showed that serum albumin 
bound two equivalents of OTA tightly. Incubation of hepatic 
or renal microsomes with [3H] OTA results in the association of 
a significant amount of protein-bound radioactivity which can 
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not be removed by repeated washing with trichloroacetic acid 
and organic solvents [Rahimtula, unpublished data). 
Preliminary evidence using ESR spectroscopy also indicates 
that OTA is able to disturb the ordered structure of hepatic 
microsomal vesicles containing spin-labelled fatty acids. 
However, it does not appear that in vivo OTA exerts a 
significant inhibitory direct effect on renal cortical calcium 
uptake activity since an increase in this activity was 
observed after OTA administration. 
The data show that in vivo OTA exerts opposite effects on 
liver and kidney in terms of both microsomal calcium uptake 
and lipid peroxidation. One possible explanation for this 
might be that OTA in the presence of cytochrome P-4 50 might be 
exerting two effects that oppose each other. As a substrate 
for cytochrome P-450, OTA would be expected to reduce the 
steady-state levels of the active cytochrome P-450-oxygen 
complex and thereby decrease the inactivation of the pump. 
However, since OTA can also stimulate lipid peroxidation in 
liver both in vivo and in vitro by a process shown to be 
mediated by cytochrome P-450 (Omar et al, 1990], the onset of 
lipid peroxidation would be expected to inhibit the calcium 
pump activity. In the liver, lipid peroxidation may be 
dominant leading to an overall inhibition of the calcium pump 
activity [Khan et al, 1989]. My results show that, under a 
variety of experimental conditions, OTA does not induce lipid 
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peroxidation in the renal cortex. It is therefore possible 
that the increase in calcium uptake activity observed could be 
due to the inhibitory effect of OTA on the steady-state level 
of the active cytochrome P-450-oxygen complex. 
However, the reason for the inability of OTA to induce 
lipid peroxidation in the renal cortex or for the involvement 
of cytochrome P-450 in OTA-dependent changes in renal 
microsomal calcium uptake rGmain to be investigated. 
, . 
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CHAPTER 5 
5. Conclusions 
1) Administration of single high dose or multiple lower 
doses of OTA to rats resulted in an increase of the renal 
cortical endoplasmic reticular ATP-dependent calcium pump 
activity. This increase is the earliest enzymatic change 
reported (within 10 min) in the kidney after OTA 
administration. 
2) Following OTA administration, lipid peroxidation levels 
and several antioxidant enzyme activities in the kidney 
were either unaltered or decreased. Thus, lipid 
peroxidation is not likely to play a significant role 
during the early stages of OTA nephrotoxicity. 
3) In vitro preincubation of rnicrosomes with NADPH had a 
profound inhibitory effect in calcium uptake. Inclusion 
of OTA was able to partly reverse the inhibition. 
Addition of OTA alone to cortical microsomes during 
calcium uptake inhibited tlle uptake process, although the 
effect was reversible. 
4) Changes in the rates of microsomal calcium uptake 
correlated with changes in the steady-state levels of the 
phosphorylated Mg2•;ca2• -ATPase intermediate suggesting 
that in vivo/in vitro conditions were affecting the rate 
of enzyme phosphorylation. 
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5) The ability of OTA analogues to restore the inhibitory 
effect of NADPH on calcium uptake indicated that the 
presence of a free carboxyl group, the chlorine atom and 
Phenylalanine moiety em OTA were all essential. 
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